TSS:Hg 10791.1

Basic information about the TSS

---

TSS ID: hg_10791.1 Species: human Chr: chr1		Start: 20786612 End: 20786693 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000312239.10 ENST00000375000.5 ENST00000419490.5 ENST00000414993.1 ENST00000443615.1 BC053327 AK023129 AK291252 BC032139 Distance: 0 GeneID: 50809 HGNC/MGI_ID: HGNC:24973 UniProt_ID: B0QZK5 B0QZK7 B0QZK9 Q5SSJ5

Gene_name: heterochromatin protein 1 binding protein 3 Gene_symbol: HP1BP3 Gene_synonyms: HP1-BP74 Gene_source: HGNC:24973

TATA-Box annotation

---

Distance to TSS:	35
Nearest PromoterID:	NM_016287
Entrez ID:	50809
Nearest Unigene:	Hs.142442
Nearest Refseq:	NM_016287
Nearest Ensembl:	ENSG00000127483
Gene Name:	heterochromatin protein 1 binding protein 3
Gene Alias:	HP1-BP74|HP1BP74
Gene Description:	heterochromatin protein 1 binding protein 3
Gene Type:	protein-coding
CpG%:	0.16
GC%:	0.751244
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HP1BP3 p2@HP1BP3 p3@HP1BP3 p5@HP1BP3 p6@HP1BP3 p7@HP1BP3 p10@HP1BP3
Sample		p1@HP1BP3	p2@HP1BP3	p3@HP1BP3	p5@HP1BP3	p6@HP1BP3	p7@HP1BP3	p10@HP1BP3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	12.08	29.80	2.14	0.78	0.39	0.39	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	12.54	26.30	2.83	0.81	0.61	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	14.66	25.27	2.51	0.96	1.93	0.39	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	9.15	23.08	1.25	0.21	0.00	0.21	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	12.37	24.75	2.02	0.00	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	13.57	19.96	2.33	0.58	1.55	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	15.91	27.45	3.05	0.87	1.31	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	11.14	25.92	2.42	0.73	0.24	0.48	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	14.32	30.13	1.92	0.64	0.85	0.43	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	11.01	46.95	6.38	0.58	0.58	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	7.28	42.04	2.83	1.21	1.21	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	10.57	54.88	3.25	0.00	0.41	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	40.14	9.35	0.32	0.97	2.74	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	31.87	6.01	0.30	0.75	2.56	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	40.84	8.34	0.88	0.22	2.20	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	29.42	5.28	0.25	1.01	2.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	27.74	5.46	0.22	1.09	1.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	28.68	2.95	0.00	0.84	1.69	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	23.99	7.46	0.00	1.07	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	32.04	5.57	0.00	0.60	1.50	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	34.62	5.61	0.40	0.94	2.27	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	32.45	5.87	0.00	1.73	3.11	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	29.73	5.04	0.39	1.29	2.46	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	23.05	3.88	0.00	0.73	1.70	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	28.89	4.90	0.26	0.52	2.06	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	30.07	5.06	0.00	0.00	1.90	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	18.13	6.59	0.00	0.00	1.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	29.70	6.13	0.47	1.18	0.71	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	28.27	4.85	0.00	0.16	1.78	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	24.97	6.33	0.00	1.09	2.35	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	23.24	5.44	0.42	0.21	3.35	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	26.77	5.08	0.59	0.59	1.95	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	29.12	6.33	0.00	1.48	3.17	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	31.50	6.27	0.49	1.48	4.45	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	28.98	5.61	0.00	0.93	2.43	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	30.66	6.90	0.38	0.96	1.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	31.68	4.29	0.41	0.00	3.27	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	23.78	4.84	0.20	1.61	2.82	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	30.52	7.02	0.27	0.27	1.62	0.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	30.97	5.04	0.72	0.24	0.72	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	25.17	7.06	0.24	0.47	2.59	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	26.06	4.54	1.02	0.88	1.17	0.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	34.38	9.70	0.84	0.42	2.95	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	31.64	5.77	1.57	1.05	2.10	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	33.13	7.43	0.40	0.60	3.01	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	32.34	8.38	0.00	0.70	5.58	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	29.99	5.52	0.72	1.20	1.92	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	33.98	6.86	0.60	0.30	1.79	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	30.88	8.86	0.72	0.96	2.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	33.16	7.68	0.40	0.61	1.62	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	30.74	7.79	0.20	2.46	1.84	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	35.36	9.56	0.00	1.56	3.11	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	181.90	13.99	13.99	0.00	0.00	0.00	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	22.71	9.94	0.35	0.71	1.06	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	27.84	5.63	1.66	2.65	1.33	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	39.43	11.75	2.52	3.36	1.68	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	43.17	5.97	0.92	1.38	3.67	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	20.74	8.75	0.65	1.94	3.57	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	16.38	8.99	0.00	1.28	0.64	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	36.46	2.51	0.94	1.89	3.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	12.69	11.28	0.00	0.00	1.41	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	18.51	10.09	0.00	2.24	1.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	47.77	5.57	1.59	0.80	5.57	2.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	35.68	5.10	0.68	1.36	3.06	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	20.79	9.75	0.32	0.00	1.95	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	19.52	8.52	0.71	0.00	2.13	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	145.48	32.33	16.16	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	157.95	23.69	0.00	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	15.60	4.88	0.00	1.46	0.98	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	23.31	4.96	0.00	0.00	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	21.58	5.16	0.47	0.47	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	40.41	3.64	0.00	0.33	1.32	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	20.42	9.90	0.00	1.86	0.62	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	20.48	7.03	0.00	1.53	1.53	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	30.57	10.61	2.38	1.58	0.48	0.32	0.32
Adipocyte - breast, donor2	11327-117E4	24.38	9.14	1.60	1.93	0.96	0.16	0.32
Adipocyte - omental, donor1	11473-119C6	34.48	9.29	0.64	0.51	0.25	0.00	0.00
Adipocyte - omental, donor2	11474-119C7	23.17	5.23	0.75	0.75	3.74	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	23.44	9.71	0.00	0.33	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	26.80	6.38	0.00	1.91	1.28	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	3.30	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	12.65	4.97	0.90	0.45	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	24.33	5.73	0.70	0.35	0.00	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	47.13	9.19	0.20	0.39	0.20	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	35.26	10.30	0.00	0.26	0.26	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	28.43	7.53	1.12	0.28	0.28	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	53.49	9.99	1.18	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	52.84	14.64	1.37	0.48	0.16	0.08	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	42.93	8.07	1.29	0.00	0.65	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	33.06	8.00	0.53	0.00	1.07	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	32.83	10.02	0.56	1.11	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	29.53	13.72	1.66	0.83	0.42	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	25.37	8.54	1.00	0.50	0.25	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	31.42	8.84	0.00	0.00	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	29.84	8.53	1.83	0.00	0.00	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	16.57	8.18	0.22	0.22	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	4.66	2.87	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	3.59	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	35.80	16.73	0.90	0.36	0.36	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	25.10	8.37	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	34.93	7.60	0.82	0.41	0.21	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	61.22	8.24	0.92	1.26	0.92	0.46	0.00
Anulus Pulposus Cell, donor2	11463-119B5	47.27	6.86	0.49	0.73	0.24	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	26.51	4.49	0.45	1.35	0.90	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	30.39	4.78	0.87	0.87	0.87	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	2.14	0.00	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	25.41	2.39	0.30	0.90	0.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	44.26	3.79	1.26	2.53	2.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	23.76	3.96	1.32	0.00	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	22.09	2.60	1.62	0.97	0.32	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	40.29	3.88	1.46	0.97	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	16.63	3.56	1.19	2.97	2.38	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	33.14	5.27	1.51	1.13	0.38	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	31.20	5.81	0.73	0.73	2.18	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	21.31	5.02	1.25	0.00	3.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	34.59	2.80	0.66	0.00	0.33	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	17.74	4.09	0.00	1.36	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	24.73	3.92	0.15	0.75	0.30	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	29.47	2.68	2.14	0.00	0.54	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	30.99	3.97	0.76	0.38	0.57	0.00	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	27.53	3.74	0.53	0.80	1.07	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	26.34	2.93	1.95	0.00	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	27.37	3.65	0.50	0.83	0.17	0.33	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	25.22	1.20	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	27.44	3.77	1.03	0.69	0.34	0.51	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	8.39	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	27.67	1.94	1.46	0.49	0.97	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	40.22	3.04	0.38	0.76	0.38	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	15.75	2.42	1.21	1.21	1.21	2.42	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	25.65	2.28	1.14	0.57	2.28	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	27.15	2.99	0.43	0.43	0.64	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	21.42	2.32	0.52	1.55	0.00	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	27.21	4.69	0.94	0.94	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	31.19	5.47	0.32	0.96	0.00	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	24.97	2.14	0.71	0.71	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	18.13	1.75	1.17	0.00	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	30.41	3.31	0.30	1.20	0.60	0.60	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	22.57	5.94	0.00	0.00	2.38	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	25.43	5.59	1.53	1.02	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	30.05	3.06	0.25	1.78	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	27.32	3.18	0.00	0.00	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	27.19	3.45	0.43	1.29	2.16	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	30.48	3.60	0.42	0.85	0.42	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	19.72	3.48	0.58	0.29	0.00	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	26.45	8.50	0.00	0.94	0.00	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	31.70	3.39	0.51	0.51	0.68	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	4.63	0.00	2.32	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	29.58	4.23	0.00	0.00	0.00	0.00	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	27.02	4.50	0.21	1.29	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	21.66	4.81	0.00	2.41	1.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	29.16	2.92	0.00	0.00	0.73	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	30.80	4.14	0.23	1.15	0.00	0.23	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	2.55	2.55	10.20	5.10	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	22.37	4.07	0.76	0.00	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	31.59	4.95	0.83	1.65	0.83	0.62	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	23.26	3.06	0.61	0.31	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	24.86	3.82	0.48	1.43	2.39	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	26.17	2.66	0.89	1.33	0.22	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	0.00	0.00	1.53	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	30.46	1.66	1.66	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	28.60	3.44	1.06	1.06	0.53	0.79	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	17.08	1.82	1.09	0.73	0.73	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	64.85	25.30	0.98	0.49	0.37	0.49	0.00
Astrocyte - cerebellum, donor2	11580-120F5	31.84	11.13	0.86	0.68	0.17	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	24.33	9.02	0.42	0.21	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	74.25	38.34	1.74	0.70	1.74	0.70	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	51.77	41.25	1.62	2.75	1.62	0.49	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	71.30	43.11	1.94	1.19	1.19	0.00	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	51.61	23.51	2.41	2.18	1.03	0.23	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	51.11	26.69	2.00	1.63	0.50	0.25	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	50.07	24.69	2.28	1.37	0.91	0.34	0.23
Basophils, donor1	12241-129G9	92.06	6.54	3.66	0.00	0.52	0.52	0.26
Basophils, donor2	12242-129H1	123.75	13.71	10.46	0.72	0.36	0.36	0.72
Basophils, donor3	12243-129H2	67.91	9.26	2.79	0.15	0.44	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	19.40	7.33	0.22	0.00	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	5.03	1.83	0.00	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	11.30	8.16	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	10.81	4.78	0.42	0.00	0.00	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	14.97	7.37	0.69	0.46	0.00	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	26.99	7.74	0.00	2.70	0.00	0.90	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	54.31	49.57	2.58	0.93	1.34	0.41	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	53.80	90.83	4.89	1.40	2.79	1.40	1.63
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	65.87	26.22	2.56	0.32	0.96	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	113.76	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	53.54	8.45	6.20	0.56	0.56	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	51.78	6.50	1.86	0.93	0.37	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	45.66	7.90	2.20	1.10	0.00	0.44	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	66.52	9.34	0.85	0.28	0.00	0.85	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	92.49	4.93	1.90	0.00	0.38	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	101.58	13.48	1.31	0.33	0.66	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	43.22	4.05	1.16	1.30	0.29	0.43	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	36.81	4.53	0.60	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	42.64	5.45	0.95	0.00	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	34.65	3.52	0.50	0.33	0.33	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	35.61	4.97	0.55	0.55	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	33.22	5.21	0.50	0.50	0.25	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	26.24	4.11	0.59	0.39	0.00	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	32.23	3.92	1.07	0.18	0.36	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	37.43	4.79	0.65	0.87	0.22	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	29.50	2.11	0.47	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	50.16	6.34	1.06	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	28.84	3.33	0.00	0.00	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	34.51	3.27	0.45	0.15	0.30	0.30	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	27.74	3.79	1.80	0.20	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	39.35	5.41	0.83	0.42	0.21	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	30.66	3.66	0.46	0.69	0.23	0.69	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	31.67	5.43	0.68	0.45	0.00	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	26.62	4.80	0.87	0.87	0.87	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	33.35	3.50	0.81	0.00	0.27	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	42.04	2.79	0.52	0.70	0.35	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	42.08	5.89	2.10	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	32.52	2.20	0.37	0.73	0.00	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	20.43	3.52	1.06	0.00	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	27.64	4.83	0.44	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	26.50	3.49	0.35	0.52	0.35	0.17	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	38.28	3.35	0.74	0.37	0.37	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	43.11	4.74	0.43	0.22	0.00	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	32.76	3.69	0.00	0.82	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	34.31	4.87	0.46	0.23	0.00	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	25.29	5.57	0.00	0.00	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	63.43	7.85	4.58	1.31	0.22	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	56.36	8.32	2.08	1.15	0.23	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	51.12	8.23	3.25	0.00	0.43	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	76.30	15.73	2.18	0.62	0.16	0.47	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	57.63	14.50	2.10	0.35	0.70	0.70	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	91.86	15.16	2.23	1.11	0.45	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	66.86	6.89	5.36	0.51	0.26	0.51	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	66.53	6.37	5.27	1.10	0.44	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	73.69	7.58	3.16	0.42	0.42	0.42	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	99.58	20.32	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	112.54	19.66	2.03	0.00	1.36	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	111.84	9.32	6.21	2.07	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	81.55	12.26	2.67	0.00	1.07	1.07	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	135.09	16.62	2.68	0.00	0.54	0.00	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	114.42	19.65	4.21	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	100.40	18.04	3.14	0.78	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	118.65	21.09	2.64	0.00	0.00	0.00	2.64
CD19+ B Cells, donor1	11544-120B5	77.26	13.15	1.64	0.82	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	81.97	10.16	2.90	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	74.21	11.61	2.52	2.52	0.00	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	121.22	147.08	3.64	0.81	2.42	0.00	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	87.89	103.87	3.99	1.20	1.20	0.80	1.20
CD34+ Progenitors, donor1	11545-120B6	68.28	8.03	2.01	0.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	69.10	7.87	2.25	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	75.15	41.71	1.50	0.75	1.50	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	75.31	38.56	1.58	0.23	0.45	0.23	0.45
CD4+ T Cells, donor1	11225-116C1	147.46	20.71	2.86	0.71	0.71	1.07	0.00
CD4+ T Cells, donor2	11306-117C1	99.82	17.76	2.45	2.45	1.84	1.22	0.61
CD4+ T Cells, donor3	11382-118B5	103.39	21.65	4.57	2.44	2.44	0.30	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	86.53	23.74	5.62	0.77	0.51	0.26	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	79.28	22.01	5.61	0.45	1.12	0.90	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	80.20	15.52	7.19	0.57	0.29	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	121.37	25.13	2.84	2.84	1.42	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	138.36	21.77	1.40	0.00	0.00	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	118.66	29.67	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	71.25	19.22	2.75	1.16	0.29	0.29	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	59.65	20.50	2.37	1.53	0.85	0.68	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	65.61	18.22	4.03	1.45	0.64	0.32	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	99.07	18.38	4.93	0.00	0.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	83.15	23.06	5.59	1.75	1.05	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	159.27	31.24	5.28	3.08	2.20	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	115.95	30.36	5.06	2.53	0.00	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	62.33	24.31	4.36	0.42	0.62	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	64.82	26.06	2.67	2.00	1.00	1.34	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	154.19	30.18	1.36	1.36	0.82	0.54	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	161.32	33.23	3.22	1.61	1.07	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	172.15	39.45	1.79	3.59	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	99.39	32.08	2.60	0.93	0.56	0.37	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	70.83	30.54	4.12	1.52	0.87	0.43	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	85.53	26.27	3.36	1.68	0.84	1.05	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	94.04	26.80	4.55	2.02	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	100.95	26.00	4.77	0.43	0.00	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	166.92	34.43	3.92	3.05	0.44	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	189.53	32.17	5.44	0.49	2.47	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	149.56	26.77	7.39	0.00	0.00	0.92	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	145.17	27.92	8.37	0.00	0.00	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	173.91	23.54	5.54	0.28	0.55	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	213.74	32.15	9.08	1.47	1.23	0.98	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	181.72	24.64	4.62	1.54	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	163.66	33.66	9.31	1.07	0.36	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	156.50	44.32	1.38	1.38	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	109.35	21.28	9.82	1.31	0.65	0.65	0.33
CD8+ T Cells, donor2	11307-117C2	87.10	16.52	6.38	3.38	1.88	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	109.33	23.48	6.82	0.50	1.26	1.01	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	11.47	9.63	1.15	1.15	0.46	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	13.18	10.54	1.20	0.72	0.96	0.00	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	13.68	12.04	1.09	1.09	1.09	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	10.81	11.11	1.80	0.90	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	12.00	7.92	0.72	0.24	0.00	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	11.37	7.05	2.05	0.23	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	10.65	12.82	0.22	0.87	0.43	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	12.63	11.32	1.05	1.05	0.53	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	10.79	11.02	0.23	0.23	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	15.70	12.08	0.30	0.60	1.21	0.00	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	11.91	13.36	0.87	1.16	0.58	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	13.32	10.66	0.53	1.07	0.00	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	24.08	14.01	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	25.96	14.57	0.91	0.91	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	22.38	20.88	0.75	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	12.97	7.20	1.44	0.36	0.00	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	10.07	8.63	0.86	0.86	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.08	6.13	0.24	0.94	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	13.94	16.16	1.58	0.63	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	14.15	11.99	0.62	1.23	0.92	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	12.50	11.54	0.96	0.64	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	10.33	13.39	0.76	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	13.40	9.85	0.39	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.83	19.67	1.51	1.51	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	24.09	23.29	0.80	0.00	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	23.08	25.88	1.40	0.00	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	34.06	28.05	3.01	1.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	56.66	3.66	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	19.76	8.89	0.49	0.99	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	26.73	8.94	0.63	0.32	0.21	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	54.77	23.57	1.73	2.08	0.69	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	35.89	5.69	1.78	0.71	0.71	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	32.77	5.01	0.91	1.37	1.14	0.23	0.00
Chondrocyte - re diff, donor2	11339-117F7	88.63	28.65	3.58	0.90	0.00	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	57.02	5.26	0.00	0.40	1.21	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	71.84	27.54	3.21	0.80	1.84	0.23	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	39.12	17.32	1.50	0.86	0.21	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	41.95	17.08	1.42	1.15	0.97	0.18	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	78.31	11.55	6.88	0.18	0.37	0.09	0.37
Corneal Epithelial Cells, donor1	11526-119I5	15.37	5.49	0.22	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	19.34	10.24	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	18.66	9.20	0.00	0.00	0.77	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	36.65	6.77	0.99	0.17	0.17	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	38.48	8.52	0.95	0.00	0.32	0.00	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	55.21	6.90	6.90	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	30.67	5.83	0.76	0.22	0.22	0.00	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	91.90	19.13	2.39	0.34	0.34	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	71.16	19.59	2.61	0.00	0.65	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	121.95	13.55	1.45	0.00	0.00	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	28.02	9.67	1.17	0.17	0.00	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	12.32	2.93	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	27.43	5.94	1.70	0.28	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	24.77	5.11	1.18	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	13.96	8.14	1.75	0.29	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	18.12	10.12	0.47	1.65	0.24	0.47	0.47
Endothelial Cells - Artery, donor3	11413-118E9	19.63	10.17	0.88	0.35	0.18	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	50.09	9.31	1.99	0.44	0.44	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	49.29	9.13	2.43	0.00	0.30	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	65.68	12.12	4.51	0.28	0.56	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	38.92	5.35	2.97	0.30	0.30	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	18.22	4.17	1.04	0.52	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	25.95	5.81	1.13	0.28	0.28	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	51.22	17.21	1.20	0.40	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	17.82	3.67	1.05	1.05	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	69.21	33.55	2.48	0.99	0.99	0.25	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	48.88	17.82	1.30	0.00	0.00	0.00	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	53.00	25.89	1.71	0.37	0.12	0.12	0.00
Endothelial Cells - Vein, donor1	11267-116G7	7.96	11.38	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	20.26	12.57	1.40	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	22.61	8.48	1.26	0.63	0.31	0.00	0.00
Eosinophils, donor1	12244-129H3	167.72	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	293.75	1.65	4.95	0.00	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	181.91	7.13	0.00	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	13.68	5.62	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	20.80	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	45.16	5.34	0.82	0.41	0.82	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	8.43	1.64	0.22	0.44	0.55	0.11	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	18.31	8.99	0.11	0.87	0.87	0.22	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	37.48	15.04	0.73	1.70	1.09	0.36	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	66.19	15.56	2.73	0.14	0.55	0.55	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	29.32	4.64	0.42	0.74	0.21	0.00	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	72.72	27.93	2.11	0.00	1.32	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	35.88	18.60	1.66	1.00	1.66	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	21.77	4.54	0.45	1.81	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	21.22	5.31	0.76	0.76	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	17.98	4.26	0.32	0.63	0.63	0.16	0.16
Fibroblast - Cardiac, donor4	11452-119A3	53.04	22.73	0.91	0.00	0.61	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	36.68	12.94	1.90	1.40	0.25	0.13	0.13
Fibroblast - Cardiac, donor6	11460-119B2	28.50	19.10	0.76	0.76	0.76	0.00	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	63.11	11.66	3.62	0.40	0.27	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	40.12	9.06	0.86	0.43	0.43	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	10.25	0.00	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	32.52	21.68	0.23	0.00	0.23	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	53.26	9.50	0.34	0.68	0.68	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	16.20	7.28	0.00	0.70	0.23	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	21.70	12.74	0.94	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	20.79	8.82	0.73	0.60	0.24	0.36	0.24
Fibroblast - Dermal, donor4	11450-119A1	31.31	21.82	1.13	1.36	0.34	0.23	0.34
Fibroblast - Dermal, donor5	11454-119A5	28.96	24.95	0.87	1.22	0.35	0.35	0.17
Fibroblast - Dermal, donor6	11458-119A9	38.33	26.15	0.49	1.62	0.65	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	45.39	16.66	0.83	0.00	0.42	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	63.40	21.48	2.10	0.52	0.26	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	38.61	19.24	0.00	2.50	1.45	0.66	0.66
Fibroblast - Gingival, donor3	11394-118C8	41.19	11.80	0.29	0.58	0.10	0.10	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	58.18	9.35	0.00	1.04	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	40.00	7.75	0.70	1.06	0.35	0.53	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	60.96	24.01	1.25	1.25	1.40	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	51.25	19.88	0.54	1.35	0.54	0.00	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	25.76	19.76	0.71	0.00	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	54.84	15.06	1.17	1.17	0.15	0.29	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	60.54	16.77	1.23	1.09	1.50	0.27	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	52.87	26.22	1.10	0.55	0.77	0.44	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	75.28	11.74	1.17	1.03	0.59	0.44	0.29
Fibroblast - Lung, donor1	11270-116H1	10.87	10.87	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	49.24	13.43	0.00	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	28.91	14.14	0.21	1.69	0.84	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	47.48	12.50	0.83	0.00	0.00	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	34.97	2.80	2.80	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	8.40	3.08	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	49.93	28.42	0.41	0.00	0.00	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	19.97	11.98	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	56.06	23.08	0.97	0.78	1.55	1.16	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	49.90	30.79	1.21	1.52	0.46	0.00	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	58.75	27.54	0.31	0.00	0.31	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	59.91	13.36	0.00	0.38	0.00	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	40.23	9.99	0.27	0.81	0.27	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	44.30	9.05	0.12	0.46	0.23	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	27.85	15.14	0.99	0.77	1.22	0.11	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	46.12	17.07	0.00	0.20	0.20	0.00	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	22.72	6.68	0.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	22.14	7.91	0.40	0.79	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	73.23	30.16	3.18	0.79	0.40	0.40	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	44.76	5.51	0.71	0.36	0.36	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	48.29	9.85	1.77	1.18	0.59	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	71.30	26.48	2.71	1.50	1.50	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	79.67	10.26	1.19	0.32	0.43	0.32	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	84.02	14.43	2.28	1.27	0.25	1.52	0.25
Fibroblast - skin normal, donor1	11553-120C5	42.82	7.38	0.98	0.00	0.33	0.49	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	99.25	34.89	2.21	1.00	0.60	0.40	0.20
Fibroblast - skin normal, donor2	11561-120D4	68.31	12.46	1.31	0.40	0.20	0.10	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	94.30	20.85	1.81	1.21	0.91	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	55.59	8.37	0.41	0.50	0.50	0.17	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	82.06	11.62	0.85	0.17	0.34	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	74.23	19.38	1.97	0.00	1.31	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	67.22	15.02	1.17	0.64	0.32	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	45.04	21.42	0.67	0.51	0.84	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	28.07	5.02	0.94	1.25	1.73	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	265.92	155.12	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	74.08	17.43	1.74	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	27.74	8.15	1.04	0.17	0.52	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	41.12	10.67	1.30	0.00	0.00	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	33.22	7.41	0.77	0.26	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	13.78	19.90	1.53	0.77	1.53	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	10.21	12.12	1.91	1.28	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	17.40	27.96	4.28	2.28	0.86	0.29	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	57.36	65.35	3.86	0.28	1.38	1.10	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	54.11	72.15	4.79	0.68	1.83	0.91	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	22.78	44.38	4.36	0.99	1.78	0.40	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	41.50	62.65	1.85	0.79	1.32	2.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	61.64	96.21	9.13	0.33	0.65	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	15.48	22.55	2.21	1.77	0.44	1.33	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	17.67	24.73	1.84	0.85	0.42	0.57	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	19.58	18.35	1.85	0.25	0.74	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	11.55	15.85	1.07	0.27	0.00	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	21.56	19.33	1.49	0.37	0.37	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	17.44	21.87	1.25	0.83	0.28	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	11.99	16.87	0.61	0.00	0.61	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	29.21	15.97	1.14	0.00	0.68	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	21.92	23.29	1.74	0.75	1.00	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	21.86	23.61	0.87	0.22	0.87	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	30.43	11.52	1.77	0.59	1.18	0.59	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	28.29	22.73	2.07	0.64	1.43	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	18.77	19.66	1.56	0.89	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	37.71	18.15	2.62	1.61	0.20	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	34.95	22.05	4.41	1.02	0.34	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	39.64	22.79	2.66	0.53	0.18	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	54.11	15.92	3.64	0.52	0.10	0.21	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	50.72	18.44	1.71	0.17	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	29.88	17.48	2.66	0.22	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	42.43	21.55	3.83	0.58	0.42	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	38.18	19.60	1.43	0.00	0.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	33.01	15.89	3.09	0.62	0.62	1.03	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	33.32	17.99	3.46	1.04	1.61	0.35	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	34.35	21.51	2.33	1.17	0.17	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	36.59	9.92	3.75	0.44	0.44	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	32.35	15.99	3.20	0.49	0.86	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	34.53	23.50	3.57	1.62	0.81	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	35.28	9.94	1.92	0.00	0.64	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	29.47	12.89	2.65	0.76	0.85	0.19	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	24.20	15.82	2.53	0.63	0.16	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	35.27	14.60	2.43	1.52	0.00	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	28.75	12.23	4.29	0.94	0.42	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	28.10	11.64	1.98	0.44	0.22	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	38.72	10.66	3.37	1.68	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	31.20	15.00	2.59	0.37	0.09	0.46	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	25.14	13.37	1.07	1.60	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	33.97	16.37	0.77	1.53	1.07	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	21.37	14.38	2.07	0.78	0.39	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	31.99	11.93	2.44	0.54	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	35.95	9.77	2.77	1.11	0.18	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	28.95	13.16	3.95	0.88	1.32	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	66.45	22.81	1.98	0.99	0.00	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	33.90	13.72	1.32	0.92	0.40	0.53	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	37.12	14.32	1.61	1.21	0.61	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	108.27	17.54	5.85	0.51	0.00	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	20.70	26.67	1.59	0.20	0.20	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	14.02	27.73	1.69	0.62	0.46	0.46	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	15.75	28.64	2.25	0.20	0.61	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	14.08	20.97	1.25	0.63	0.31	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	10.74	18.65	1.41	0.00	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	19.83	38.28	2.77	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	27.22	39.60	0.00	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	23.21	24.76	1.55	0.77	0.77	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	24.07	20.86	4.81	0.00	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	33.04	41.73	3.48	1.74	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	19.53	25.06	2.60	0.98	0.33	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	31.71	30.47	6.18	0.82	2.06	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	36.65	0.00	3.33	10.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	34.12	28.52	2.80	1.40	1.12	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	28.11	23.53	1.31	1.96	0.65	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	27.68	42.78	3.36	4.19	2.52	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	42.30	40.08	2.54	0.95	1.59	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	24.80	22.08	3.40	0.68	0.34	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	25.06	35.50	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	39.52	29.21	2.86	0.00	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	23.68	15.69	1.48	0.59	0.59	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	18.64	18.64	6.78	0.00	6.78	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	36.86	29.41	4.56	1.66	0.83	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	41.88	34.75	2.76	2.53	0.46	0.92	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	21.07	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	50.36	29.22	2.31	1.54	1.15	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	30.97	29.01	2.28	0.33	2.28	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	26.75	36.12	2.01	0.67	1.34	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	44.69	16.95	3.85	3.08	0.39	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	45.87	41.08	3.42	0.68	1.37	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	22.36	49.70	0.00	2.48	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	41.05	33.03	0.94	2.36	1.42	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	39.83	25.35	1.21	2.41	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	40.69	32.05	1.53	1.02	1.02	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	55.84	26.72	1.99	1.60	2.39	0.40	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	50.82	28.61	1.48	0.99	1.97	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	62.56	24.79	0.00	1.18	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	39.67	32.67	2.92	0.58	1.17	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	43.89	22.82	2.19	2.63	2.19	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	33.06	28.82	2.54	2.54	1.70	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	47.75	23.88	2.39	2.39	1.79	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	40.28	20.38	2.43	0.49	0.97	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	21.68	3.42	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	21.21	5.41	1.25	1.25	1.25	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	22.49	11.24	0.00	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	31.08	7.93	0.00	1.90	0.95	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	19.22	3.76	0.00	0.84	0.42	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	34.35	17.87	1.16	1.28	0.81	0.23	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	35.28	22.45	0.68	1.86	1.18	0.17	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	34.13	21.61	0.00	0.91	0.91	0.23	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	32.25	18.04	1.20	1.75	0.77	0.33	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	28.58	21.28	0.86	0.43	0.21	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	33.15	15.50	0.22	1.51	0.43	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	30.76	19.05	0.50	0.75	0.87	0.25	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	26.93	18.36	0.69	0.69	0.34	0.00	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	29.47	15.70	0.64	0.96	0.32	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	37.49	8.39	0.56	0.00	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	12.98	3.03	1.73	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	5.29	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	29.63	10.23	0.71	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	20.34	4.36	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	13.46	12.59	0.35	0.70	0.35	0.00	0.17
Hepatocyte, donor1	11523-119I2	38.74	10.90	2.42	2.42	2.42	0.00	1.21
Hepatocyte, donor2	11603-120I1	30.17	8.62	1.08	0.00	2.15	1.08	0.00
Hepatocyte, donor3	11684-122I1	39.27	13.50	0.61	1.23	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	93.99	95.29	1.31	4.57	1.96	0.00	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	45.09	25.52	1.05	2.27	0.70	0.17	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	32.24	7.27	0.27	0.14	0.41	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	47.76	44.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	53.40	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	108.33	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	23.53	41.53	1.38	1.38	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	17.52	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	23.74	0.00	0.00	0.00	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	38.44	23.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	36.57	0.00	0.00	0.00	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	60.10	37.36	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	20.01	16.67	0.00	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	14.52	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	41.03	37.06	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	18.85	13.30	0.00	1.11	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	41.91	0.00	0.00	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	23.93	22.05	0.63	0.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	24.75	0.00	0.00	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	29.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	23.90	29.72	2.58	0.00	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	25.76	14.49	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	35.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	19.56	22.00	0.00	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	27.71	15.53	0.84	0.00	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	21.70	31.34	0.80	0.00	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	14.77	13.85	0.00	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	60.32	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	15.11	16.99	0.47	0.47	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	24.49	14.51	0.00	1.81	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	19.37	20.45	1.08	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	34.30	22.87	2.54	0.00	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	29.97	22.96	0.64	0.64	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	16.40	27.34	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	29.99	22.14	0.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	36.50	0.00	0.00	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	41.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	16.05	16.36	0.00	0.00	0.31	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	24.58	33.36	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	31.43	6.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	18.08	38.94	0.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	37.62	15.49	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	32.42	3.24	0.00	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	20.93	18.31	0.87	0.00	0.87	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	24.75	20.25	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	27.88	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	25.60	18.14	2.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	13.85	0.00	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	34.20	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	21.17	20.25	0.92	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	30.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	37.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	14.80	12.69	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	22.19	8.40	0.90	0.16	0.33	0.16	0.24
Keratinocyte - epidermal, donor2	11349-117G8	8.78	4.69	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	28.96	13.73	0.28	0.85	0.28	0.00	0.19
Keratinocyte - oral, donor1	11251-116E9	59.26	19.41	1.02	1.14	0.57	0.34	0.45
Keratocytes, donor1	11527-119I6	25.10	27.85	0.69	0.34	0.00	0.00	0.34
Keratocytes, donor2	11607-120I5	17.58	8.20	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	19.76	9.29	1.19	0.40	0.40	0.40	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	120.89	6.59	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	19.42	11.87	1.08	3.24	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	69.31	16.15	1.38	0.81	0.81	0.81	0.12
Lens Epithelial Cells, donor3	11690-122I7	46.32	5.95	1.11	0.00	0.10	0.10	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	42.33	6.52	0.71	0.59	0.59	0.24	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	28.74	5.86	0.56	0.28	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	34.47	11.49	0.79	0.79	1.26	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	23.12	3.76	1.61	0.54	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	25.53	4.10	0.32	0.32	0.63	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	24.80	3.99	0.86	0.54	0.43	0.22	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	32.42	6.98	0.82	0.41	1.23	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	20.23	3.54	0.25	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	26.04	4.93	0.56	1.13	1.13	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	19.78	6.33	1.19	0.40	0.00	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	21.71	5.43	0.97	0.78	0.39	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	21.29	2.96	0.19	0.19	0.37	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	26.83	6.97	0.70	0.70	0.70	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	20.75	5.49	0.48	1.19	0.48	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	24.04	4.26	0.69	0.55	0.27	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	23.71	3.70	0.92	0.62	0.62	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	15.90	4.36	0.31	0.62	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	26.90	4.39	1.28	0.73	0.18	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	30.61	5.27	0.66	0.66	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	21.09	3.22	0.29	0.29	0.29	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	21.91	2.99	0.75	0.50	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	29.10	6.30	0.48	0.97	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	29.35	5.12	0.54	0.27	0.81	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	25.43	5.45	1.67	1.06	1.51	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	23.33	3.11	0.52	0.52	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	29.52	5.03	0.42	0.84	0.21	0.21	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	27.52	6.77	0.90	0.90	0.00	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	19.95	8.94	1.38	2.06	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	22.95	3.57	0.19	0.56	0.56	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	18.45	2.86	0.64	1.06	0.21	0.21	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	19.38	4.36	0.48	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	19.85	3.64	0.33	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	20.44	4.34	0.87	0.74	1.12	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	35.91	4.44	0.74	0.00	0.74	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	19.03	4.69	0.00	0.00	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	19.39	4.54	0.14	0.69	0.27	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	25.09	6.43	1.29	0.96	0.00	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	29.52	6.70	0.30	0.91	0.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	29.95	3.22	0.42	0.98	0.84	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	28.09	5.33	0.71	1.07	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	17.45	3.39	0.97	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	18.05	3.11	0.78	0.31	0.62	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	18.62	6.80	0.00	0.36	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	27.11	4.25	0.65	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	14.83	3.53	0.71	0.94	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	30.32	5.45	0.87	0.50	0.62	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	15.62	4.61	0.26	0.26	0.00	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	21.78	2.98	1.19	0.30	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	4.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	27.62	8.44	0.00	0.77	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	18.56	8.91	1.48	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	24.96	9.31	0.42	1.27	1.69	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	16.18	9.14	0.00	0.00	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	18.68	7.47	2.80	1.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	15.97	12.37	1.03	1.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	23.79	9.52	1.19	1.19	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	24.43	11.08	1.36	0.00	0.00	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	25.59	12.21	0.58	3.20	0.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	26.56	12.15	1.80	2.25	2.70	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	29.40	12.06	0.95	0.27	0.81	0.14	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	27.22	10.27	0.51	1.03	2.05	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	28.58	7.76	1.76	0.71	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	13.99	6.66	0.00	0.00	0.00	0.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	22.41	11.21	0.51	3.06	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	24.55	10.67	0.80	1.07	1.33	0.80	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	35.33	13.60	1.13	1.32	1.13	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	24.54	5.52	1.84	3.68	1.23	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	22.83	11.42	2.45	0.82	0.82	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	33.53	11.04	1.25	1.04	1.67	0.21	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	27.47	12.61	0.84	2.24	1.96	0.56	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	20.61	9.27	1.03	2.06	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	31.93	9.00	1.45	2.90	1.45	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	26.01	9.27	1.20	0.60	1.20	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	28.22	15.49	2.77	1.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	32.52	12.73	0.71	0.71	2.12	0.00	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	23.23	8.85	0.37	0.37	0.37	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	19.57	8.06	1.15	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	24.18	11.13	1.92	0.38	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	17.55	7.93	0.57	6.23	1.13	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	27.90	9.85	0.00	1.64	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	24.85	9.94	0.00	2.71	0.45	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	25.14	12.21	0.00	1.44	2.15	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	20.91	5.98	0.75	0.75	2.24	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	22.30	11.52	0.00	2.23	2.60	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	21.97	9.05	3.02	0.86	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	25.69	17.13	0.86	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	21.66	8.33	0.67	1.67	2.33	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.89	12.07	0.60	0.00	1.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	17.77	14.93	2.13	1.42	1.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	19.59	12.03	1.03	1.37	1.03	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	23.62	11.27	0.54	1.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	16.83	9.43	2.02	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	24.82	10.37	0.74	1.48	0.74	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	37.21	9.30	1.16	0.00	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	11.64	4.23	0.00	0.00	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	27.21	11.60	0.40	2.80	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	23.26	12.36	2.18	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	19.93	9.20	0.77	3.07	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	23.18	8.39	0.49	0.49	1.48	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	17.88	8.47	0.94	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	25.64	12.57	1.51	0.00	2.01	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	23.43	14.87	0.45	0.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	13.77	3.44	1.72	3.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	26.28	12.47	0.45	2.23	0.89	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	27.76	14.08	1.96	0.39	0.39	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	25.73	7.26	1.32	0.66	1.98	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	26.98	9.86	0.52	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	30.19	8.75	0.00	1.75	0.88	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	25.72	10.06	0.56	0.56	1.68	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	23.85	12.37	2.21	2.65	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.53	12.34	1.16	0.77	1.54	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.23	8.61	1.01	1.52	1.52	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	28.36	8.65	0.48	0.00	1.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	24.25	12.32	0.00	2.39	2.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	19.44	9.72	0.00	1.22	0.61	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	25.59	6.92	1.38	2.08	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	27.36	14.82	1.90	1.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	21.17	8.78	1.55	2.58	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	15.72	9.67	1.81	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	21.55	11.09	0.95	2.85	1.27	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	19.19	9.60	2.13	0.00	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	16.09	5.17	0.57	1.15	1.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	21.60	8.74	1.03	1.03	0.51	0.00	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	20.51	8.49	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	17.02	8.51	2.27	1.70	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	24.13	10.40	1.66	0.42	0.83	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	20.36	12.53	0.00	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	13.78	8.35	0.84	0.84	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	16.26	11.62	0.93	2.32	0.46	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	19.40	5.35	0.00	0.00	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	22.99	9.62	1.07	0.00	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	24.25	7.68	1.62	2.02	0.81	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	21.11	6.42	2.75	0.00	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	14.23	5.33	1.78	0.00	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	16.53	7.98	2.85	1.14	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	12.27	15.34	2.30	0.00	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	14.23	4.38	1.64	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.47	9.80	1.78	0.00	0.45	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	17.16	8.84	1.30	0.52	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11.94	8.62	1.99	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	18.71	8.31	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	46.27	5.70	0.68	0.23	0.46	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	29.36	4.77	0.37	0.18	0.18	0.37	0.18
Macrophage - monocyte derived, donor3	11389-118C3	30.41	8.78	0.92	0.39	0.66	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	19.12	3.19	0.53	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	38.82	8.71	0.95	0.00	0.32	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	35.72	10.70	0.56	0.28	0.14	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	47.03	23.62	0.20	0.80	0.50	0.40	0.20
Mammary Epithelial Cell, donor2	11350-117G9	29.53	21.72	0.58	0.58	1.16	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	18.96	7.73	0.50	0.25	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	189.14	35.25	9.49	1.36	0.68	0.68	0.68
Mast cell, donor1	11563-120D6	94.30	17.63	4.11	0.76	0.32	0.11	0.65
Mast cell, donor2	11565-120D8	117.98	11.29	2.38	0.59	0.30	0.89	0.30
Mast cell, donor3	11566-120D9	127.42	9.23	2.03	0.23	0.23	0.45	0.00
Mast cell, donor4	11567-120E1	121.44	7.27	2.48	0.71	0.00	0.00	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	86.39	22.84	4.66	1.22	1.00	0.44	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	66.54	16.34	0.58	1.17	1.17	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	81.80	19.85	5.39	1.26	1.15	0.34	0.34
Mast cell, expanded, donor8	11941-126A6	102.26	21.26	3.68	1.00	0.84	0.33	0.00
Melanocyte - dark, donor1	11502-119F8	47.06	9.75	1.29	0.60	0.80	0.00	0.10
Melanocyte - dark, donor2	11582-120F7	24.57	9.00	0.35	1.04	1.04	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	55.42	17.17	2.17	0.72	1.09	0.43	0.07
Melanocyte - light, donor1	11274-116H5	17.16	5.88	0.94	0.00	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	18.43	6.82	0.68	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	4.34	2.60	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	16.66	10.62	3.12	0.52	0.62	0.10	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	28.78	15.33	1.88	1.08	0.00	0.27	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	45.80	19.29	3.75	1.87	0.80	0.54	0.00
Meningeal Cells, donor1	11493-119E8	66.74	32.63	1.24	0.12	0.25	0.25	0.37
Meningeal Cells, donor2	11573-120E7	44.45	20.69	0.88	1.32	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	40.18	21.68	1.30	0.49	0.73	0.24	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	45.62	19.96	0.86	0.29	0.86	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	34.42	5.74	1.21	0.00	0.20	0.30	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	2.63	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	7.85	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	17.22	9.33	0.72	2.15	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	42.35	6.35	1.27	0.64	0.64	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	28.65	9.05	0.00	1.51	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	22.85	14.06	0.22	0.00	0.66	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	23.38	14.61	0.73	0.00	2.19	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	17.19	10.64	0.20	0.00	0.20	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	55.13	5.12	0.42	0.83	0.28	0.28	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	18.21	9.66	1.12	0.74	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	50.92	27.24	0.53	1.32	1.05	0.13	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	21.66	3.56	0.59	0.59	0.59	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	14.09	15.37	1.28	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	29.06	17.01	0.71	0.35	0.00	0.35	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	47.85	23.45	0.31	0.31	1.25	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	19.59	13.06	0.00	0.00	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	29.70	3.98	1.33	0.00	0.00	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	37.03	6.01	1.50	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	27.75	4.99	1.01	0.43	0.29	0.51	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	51.31	4.05	1.35	0.00	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	32.26	1.97	1.48	0.25	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	27.38	2.65	0.88	0.29	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	65.68	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	30.68	3.72	0.62	0.00	0.00	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	18.05	2.49	0.83	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	30.11	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	27.28	1.75	0.50	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	33.51	3.72	0.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	25.00	2.64	0.61	0.00	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	23.76	3.96	1.19	0.00	0.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	68.41	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	10.62	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	19.38	1.52	0.38	0.38	0.00	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	30.27	2.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	19.95	3.82	0.64	0.64	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	14.73	3.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	22.35	2.68	0.89	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	33.53	0.00	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	22.58	3.01	1.00	0.25	0.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	16.16	2.61	0.48	0.24	0.00	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	28.75	1.66	0.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	17.96	4.84	0.23	0.46	0.23	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	18.51	2.10	0.42	0.21	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	19.16	2.85	0.20	0.20	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	19.74	1.50	0.43	0.21	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	15.78	1.78	0.67	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	14.24	3.07	0.22	0.44	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	18.76	0.51	0.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	18.23	1.66	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	18.48	1.90	0.82	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	17.06	1.76	0.59	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	23.99	2.18	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	6.73	1.92	0.48	0.48	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	20.01	4.40	0.80	0.40	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	2.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	19.02	2.00	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	16.64	2.63	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	24.28	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	17.29	1.28	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	14.38	3.22	0.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	16.01	5.57	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	39.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	13.33	4.44	0.68	0.68	0.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	14.00	1.75	1.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	14.91	1.78	0.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	10.94	3.37	0.56	0.00	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	14.13	2.08	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	18.07	2.33	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	15.08	5.13	0.60	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	13.77	2.09	0.42	0.00	0.00	0.83	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	20.32	0.00	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	14.23	0.57	0.00	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	13.54	2.49	0.41	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	16.07	2.33	0.78	0.26	0.00	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	16.73	0.43	0.43	0.00	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	17.79	0.64	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	15.48	1.60	0.53	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	25.74	2.69	0.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.01	1.98	0.71	0.14	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	8.92	3.50	0.64	0.00	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	21.67	3.32	0.44	0.22	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	14.79	2.65	0.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	15.06	1.70	0.57	0.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	14.26	3.20	0.25	0.49	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	20.20	1.30	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	16.76	1.47	0.59	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	26.53	2.31	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	29.67	2.89	0.00	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	22.33	2.98	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	24.95	3.56	0.00	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	23.00	4.60	0.66	0.99	0.00	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	22.09	2.10	0.00	0.00	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	34.79	2.77	0.59	0.00	0.40	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	41.91	0.93	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	27.04	1.13	0.38	0.38	0.38	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	24.50	2.40	0.53	0.53	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	35.51	2.71	0.11	0.23	0.11	0.23	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	16.94	2.95	0.00	0.00	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	33.71	3.66	0.73	0.37	0.37	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	20.22	4.67	0.00	1.56	1.56	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	37.41	1.60	0.00	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	0.00	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	21.21	1.01	0.00	0.00	2.02	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	22.35	4.22	0.42	0.42	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	19.07	0.00	0.00	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	20.98	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	18.63	1.62	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	1.51	0.00	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	51.39	5.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	13.05	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	25.10	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	38.56	5.82	1.51	0.22	0.86	0.22	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	34.49	5.23	0.52	0.00	1.57	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.02	18.02	0.67	0.67	2.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	17.95	7.93	0.00	0.42	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	61.99	10.84	1.14	0.57	2.47	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	92.56	15.96	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	11.56	8.84	0.68	0.00	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	69.83	33.08	1.84	1.84	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	14.65	11.72	0.00	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	27.89	9.99	0.00	0.00	1.39	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	17.83	13.24	0.00	0.54	0.81	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	51.30	14.09	0.63	0.00	0.63	0.00	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	144.75	77.94	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	19.85	10.92	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	27.61	4.87	0.27	0.27	0.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	14.28	7.93	0.91	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	22.21	12.41	0.65	0.33	0.65	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	48.66	8.20	1.09	1.09	0.36	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	20.16	8.49	0.00	0.53	2.12	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.81	6.60	0.00	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	54.48	4.92	0.33	0.98	1.64	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	12.85	6.02	0.49	0.00	1.63	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	52.91	8.64	1.41	0.35	0.71	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	18.99	11.25	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	23.90	9.19	0.00	0.00	2.76	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	18.96	14.14	0.64	0.00	0.32	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	56.56	6.21	0.69	2.41	4.14	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	179.52	17.70	0.00	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	60.82	10.03	0.89	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	19.90	12.70	0.00	0.85	1.69	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	32.04	5.70	0.71	0.47	0.71	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	21.89	11.59	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	261.81	63.19	9.03	45.14	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	34.66	9.00	1.00	0.00	1.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	52.75	4.51	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.87	7.54	0.00	0.00	1.59	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	17.64	9.29	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	35.57	5.30	0.00	0.38	1.51	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	17.92	10.43	0.33	0.33	1.30	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	22.66	9.59	0.00	0.00	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	61.51	6.78	1.36	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	17.64	7.06	0.00	0.00	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	15.29	5.32	1.33	0.00	1.33	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	22.32	6.45	0.50	0.00	0.50	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	22.97	10.34	0.38	0.00	1.15	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	48.09	10.89	0.00	0.30	0.91	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	41.99	6.19	0.44	0.00	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	10.84	6.78	0.00	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	178.83	25.55	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	17.68	9.15	0.00	1.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	23.61	5.67	1.26	0.00	1.26	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	19.98	5.75	1.21	0.30	0.91	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.87	4.75	0.00	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	47.61	3.40	2.27	2.27	2.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	116.33	5.06	5.06	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	27.58	8.94	1.37	0.37	0.25	0.25	0.12
Myoblast, donor2	11322-117D8	38.17	12.47	0.96	0.77	0.38	0.77	0.19
Myoblast, donor3	11398-118D3	41.20	16.14	0.84	0.00	0.00	0.50	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	50.49	44.22	2.19	1.02	1.31	0.88	1.17
Natural Killer Cells, donor1	11230-116C6	103.33	16.91	5.54	0.62	0.00	0.92	0.00
Natural Killer Cells, donor2	11311-117C6	78.71	11.76	10.86	1.51	0.60	1.81	0.60
Natural Killer Cells, donor3	11387-118C1	93.13	14.72	6.81	1.10	1.29	0.92	0.55
Neural stem cells, donor1	11275-116H6	107.43	35.57	5.08	1.09	0.36	0.00	0.00
Neural stem cells, donor2	11352-117H2	192.56	40.44	1.93	0.00	0.00	0.00	1.93
Neurons, donor1	11494-119E9	89.89	21.62	6.83	3.41	0.00	0.00	0.00
Neurons, donor2	11574-120E8	107.88	18.27	4.84	2.20	1.32	0.22	0.00
Neurons, donor3	11655-122E8	57.55	33.71	1.64	4.93	1.64	0.00	0.00
Neutrophils, donor1	11233-116C9	113.22	5.57	3.71	2.78	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	136.25	0.00	5.80	14.49	5.80	2.90	2.90
Neutrophils, donor3	11390-118C4	158.21	6.11	6.11	0.00	0.00	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	77.89	8.31	0.83	1.66	0.71	0.36	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	23.44	2.60	0.00	0.65	0.33	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	29.08	7.22	0.60	0.40	0.20	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	34.41	8.40	0.69	1.79	0.69	0.28	0.00
Olfactory epithelial cells, donor2	11934-125I8	34.45	9.84	0.14	3.33	2.03	1.16	0.43
Olfactory epithelial cells, donor3	11935-125I9	34.96	7.83	0.23	0.45	1.48	0.23	0.11
Olfactory epithelial cells, donor4	11936-126A1	42.66	11.01	0.49	0.58	0.29	0.19	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	55.37	13.24	1.81	0.60	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	32.33	4.04	0.43	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	13.72	1.14	1.14	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	13.03	1.24	0.00	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	27.17	8.01	0.20	0.20	0.00	0.39	0.00
Osteoblast, donor2	11354-117H4	43.54	18.96	0.00	0.70	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	37.15	13.86	0.71	0.89	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	51.64	14.15	1.01	1.35	1.18	0.34	0.25
Pericytes, donor1	11491-119E6	30.15	4.01	1.00	0.22	0.33	0.00	0.00
Pericytes, donor2	11571-120E5	28.97	6.11	0.68	0.00	0.23	0.00	0.23
Pericytes, donor3	11652-122E5	21.36	8.95	1.22	0.61	0.00	0.00	0.20
Perineurial Cells, donor1	11499-119F5	48.60	18.99	0.57	0.34	0.34	0.23	0.23
Perineurial Cells, donor2	11579-120F4	36.99	11.96	0.64	0.46	0.00	0.09	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	141.52	16.89	4.46	0.64	0.32	0.32	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	64.40	14.45	2.20	1.96	0.24	0.73	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	74.28	12.17	5.05	1.04	0.78	0.26	0.26
Placental Epithelial Cells, donor1	11278-116H9	15.07	2.87	0.00	0.24	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	29.94	5.54	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	23.36	5.50	0.00	0.59	0.39	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	13.61	5.06	1.58	0.63	1.27	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	31.51	6.19	0.94	0.38	0.00	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	85.76	16.19	2.22	0.65	1.04	0.52	0.26
Preadipocyte - breast, donor2	11328-117E5	33.32	5.18	0.23	1.80	1.13	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	32.61	5.43	0.53	0.32	0.32	0.43	0.00
Preadipocyte - omental, donor2	11329-117E6	42.34	11.78	0.87	0.00	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	30.94	8.59	1.72	0.43	0.86	0.29	0.00
Preadipocyte - perirenal, donor1	11469-119C2	12.80	5.91	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	16.58	7.37	0.92	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	39.13	15.58	0.00	2.30	0.71	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	30.48	8.17	1.19	1.02	0.51	0.34	0.00
Preadipocyte - visceral, donor1	11280-116I2	46.57	17.79	0.75	0.47	0.65	0.28	0.19
Preadipocyte - visceral, donor2	11357-117H7	41.88	11.04	0.00	2.76	0.00	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	28.11	9.93	1.15	0.94	0.21	0.21	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	30.47	26.10	2.26	0.91	0.60	0.15	0.45
Prostate Epithelial Cells, donor2	11331-117E8	21.80	4.87	1.90	0.81	0.41	0.14	0.00
Prostate Epithelial Cells, donor3	11404-118D9	24.74	3.31	0.43	0.67	0.37	0.24	0.18
Prostate Stromal Cells, donor1	11254-116F3	32.69	18.22	0.57	0.91	0.91	0.46	0.11
Prostate Stromal Cells, donor2	11332-117E9	41.78	17.75	0.72	2.15	1.43	0.54	0.00
Prostate Stromal Cells, donor3	11405-118E1	33.89	8.86	0.63	1.98	0.63	0.31	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	32.12	12.77	0.73	0.36	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	37.91	8.46	1.04	0.62	0.21	0.07	0.07
Renal Epithelial Cells, donor1	11517-119H5	18.77	11.16	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	28.45	12.09	0.71	0.71	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	46.37	9.21	0.53	0.64	0.85	0.42	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	25.19	6.81	0.00	1.36	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	25.07	10.24	0.54	0.40	0.27	0.13	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	38.85	14.65	0.67	1.33	0.44	0.44	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	9.32	2.66	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	30.15	9.68	0.22	0.66	0.00	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	34.48	11.29	0.63	0.00	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	18.31	3.88	0.00	0.28	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	35.70	15.03	0.00	0.27	0.00	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	15.60	6.75	0.00	0.00	0.00	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	31.82	12.34	0.00	0.96	0.77	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	41.49	14.78	0.78	0.78	0.78	0.00	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	47.75	12.51	0.28	0.00	1.14	0.28	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	19.55	10.29	0.00	2.06	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	29.36	8.78	1.00	0.75	0.50	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	100.63	12.83	2.00	0.67	0.40	0.13	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	51.82	31.27	3.57	0.89	0.00	0.00	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	52.84	51.73	8.26	2.20	0.00	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	128.19	62.65	8.12	0.58	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	123.00	39.27	3.77	1.17	0.26	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	59.19	40.02	3.48	1.89	0.50	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	85.10	49.63	4.02	0.67	0.78	0.33	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	104.69	51.97	4.71	2.23	1.36	0.62	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	61.42	40.79	4.78	1.52	1.05	0.58	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	90.60	55.24	6.01	1.39	0.46	0.00	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	67.77	35.32	3.15	0.14	0.27	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	63.69	38.57	3.33	1.97	0.30	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	80.28	45.69	4.48	0.90	0.54	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	64.99	43.32	3.16	1.43	0.57	0.43	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	56.55	34.02	2.90	1.82	0.21	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	58.19	44.25	3.54	1.11	1.55	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	55.44	33.65	3.82	0.19	0.19	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	62.51	38.20	4.38	0.84	0.47	0.09	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	94.71	51.30	3.19	0.94	1.32	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	76.31	32.25	3.58	1.06	0.53	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	67.94	37.67	5.35	2.34	0.19	0.10	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	70.46	42.97	5.16	2.86	0.95	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	66.43	33.64	4.49	0.53	0.64	0.11	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	70.36	35.88	2.80	3.64	1.68	0.28	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	72.97	42.21	4.61	0.85	1.20	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	66.19	32.09	4.01	0.18	0.18	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	64.38	36.30	3.56	2.58	0.25	0.37	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	72.40	45.40	5.51	2.42	0.81	0.81	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	60.62	37.98	4.48	0.47	1.18	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	64.48	40.87	2.58	2.58	0.60	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	73.43	41.86	4.91	1.87	0.94	0.23	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	53.50	36.70	6.01	0.21	0.62	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	74.33	42.25	2.65	5.97	1.11	0.00	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	69.35	39.48	4.18	0.63	0.63	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	61.91	38.89	4.85	0.94	0.81	0.54	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	66.24	33.72	3.24	0.68	0.34	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	77.31	47.62	5.59	0.96	0.77	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	53.30	33.18	3.61	0.86	0.52	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	69.00	34.43	4.94	0.82	0.82	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	78.31	47.94	5.09	2.13	0.66	0.00	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	58.29	32.89	3.58	0.85	0.68	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	79.45	45.57	2.66	1.18	0.44	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	75.43	48.51	3.73	1.07	0.00	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	70.24	37.89	4.84	0.69	0.41	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	64.29	39.29	4.52	1.19	0.95	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	89.69	49.58	4.84	0.60	0.40	0.40	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	76.19	36.45	5.37	1.13	0.38	0.75	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	88.04	40.53	6.64	2.10	0.70	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	75.86	35.66	4.84	0.30	0.60	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	65.97	37.45	4.77	1.35	1.22	0.49	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	173.50	90.97	10.19	0.73	1.60	1.02	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	62.06	66.32	4.26	2.43	0.61	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	59.98	39.78	5.73	2.41	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	72.15	55.87	4.98	1.58	0.90	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	83.27	65.90	5.69	3.00	1.20	0.60	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	110.87	40.62	5.55	1.30	0.12	1.53	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	67.88	49.52	2.77	1.07	0.43	0.64	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	84.14	72.72	5.41	0.60	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	21.82	9.78	0.38	0.38	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	34.02	13.61	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	26.95	15.55	0.88	1.10	0.66	0.44	0.88
Sebocyte, donor1	11220-116B5	43.27	15.34	0.55	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	12.87	6.43	0.46	1.38	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	13.81	3.71	0.82	0.21	0.00	0.21	0.00
Sertoli Cells, donor1	11255-116F4	41.41	13.25	0.00	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	36.72	2.82	0.00	5.65	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	38.36	8.89	1.06	0.35	0.35	0.09	0.00
Skeletal Muscle Cells, donor2	11358-117H8	14.46	2.17	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	26.75	11.70	0.00	1.67	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	28.59	19.32	0.31	0.79	0.31	0.31	0.00
Skeletal Muscle Cells, donor5	11455-119A6	24.53	15.46	0.45	0.89	0.74	0.30	0.15
Skeletal Muscle Cells, donor6	11459-119B1	34.17	22.62	0.62	0.77	0.77	0.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	52.80	22.18	0.50	0.63	0.88	0.50	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	34.67	16.12	1.57	1.14	0.43	0.57	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	36.11	22.62	0.69	0.69	0.99	0.40	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	32.94	12.22	1.18	0.25	0.34	0.08	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	21.71	10.86	0.00	0.00	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	28.21	5.37	0.69	0.41	0.28	0.14	0.00
Skin - palm, donor1	10286-104F7	233.69	5.37	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	8.51	5.19	0.58	0.29	0.72	0.29	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	73.61	48.26	10.63	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	10.13	6.23	0.13	0.39	0.26	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	26.41	6.81	0.70	0.70	0.42	0.28	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	24.90	7.31	0.56	0.84	0.42	0.14	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	143.36	75.27	5.71	0.85	1.06	0.00	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	25.03	6.00	0.67	0.37	0.30	0.15	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	20.98	4.32	1.54	0.62	1.85	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	36.46	7.34	0.22	0.44	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	27.63	6.47	0.59	0.00	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	32.49	5.97	0.66	0.44	0.44	2.65	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	17.72	4.33	0.00	0.00	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	29.36	6.95	1.55	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	61.05	17.01	0.00	1.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	21.03	3.73	0.13	0.13	0.27	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	31.70	8.87	0.22	1.33	1.11	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	28.68	5.76	0.51	0.26	0.13	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	30.28	12.05	1.30	0.33	0.33	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	38.98	12.40	2.36	0.89	0.59	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	27.33	6.55	1.28	0.14	0.43	0.14	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	13.34	7.16	0.16	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	35.31	8.83	0.30	0.91	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	35.86	7.32	0.00	0.00	0.25	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	23.84	3.81	0.95	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	38.05	13.57	0.44	0.29	0.59	0.15	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	24.54	12.91	0.00	1.08	0.43	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	27.50	15.11	0.31	0.63	0.31	0.10	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	19.80	5.57	0.62	0.15	0.31	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	11.86	7.55	1.08	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	17.63	7.17	0.30	0.90	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	20.14	7.17	0.34	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	55.68	10.05	0.24	0.94	1.02	0.24	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	35.63	7.55	0.70	0.20	0.30	0.10	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	24.12	5.23	0.46	0.23	0.00	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	16.30	3.62	0.00	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	33.12	25.17	0.79	0.79	1.06	0.00	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	53.53	15.45	0.67	0.13	0.53	0.13	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	27.80	9.77	0.63	1.38	0.63	0.38	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	31.45	3.55	0.76	0.00	0.51	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	36.34	12.82	0.60	0.30	0.45	0.00	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	29.26	5.25	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	147.31	6.46	7.75	2.58	1.29	12.92	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	27.90	6.98	0.47	0.47	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	17.67	3.03	0.50	0.00	0.00	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	16.30	4.07	0.31	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	13.57	5.31	0.59	0.29	0.29	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	47.82	24.49	0.50	0.08	0.00	0.17	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	39.71	6.54	0.00	0.00	0.93	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	17.85	5.18	0.72	0.00	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	19.63	8.92	0.51	1.27	0.25	0.76	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	20.12	5.26	0.38	0.75	0.19	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	38.43	16.49	1.12	0.42	0.42	0.28	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	31.92	8.97	0.34	0.00	0.34	0.17	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.76	3.33	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	25.93	3.18	0.49	0.24	0.49	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	37.78	9.50	1.10	0.66	0.22	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	33.35	7.90	0.00	0.29	0.29	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	38.48	5.64	0.78	0.19	0.97	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	25.12	6.08	0.00	0.79	1.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	29.38	5.21	0.00	0.74	1.49	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	34.14	6.11	1.08	1.08	1.08	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	24.98	7.95	0.00	0.28	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	29.15	17.33	0.79	0.00	1.18	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	27.17	4.57	1.02	1.02	1.52	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	33.94	2.40	0.80	0.80	0.00	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	33.44	4.18	0.42	0.42	0.84	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	44.92	7.33	0.46	0.92	0.00	0.46	0.46
Synoviocyte, donor1	11291-117A4	37.70	5.89	1.18	0.84	0.50	0.17	0.17
Synoviocyte, donor2	11368-117I9	31.18	5.20	0.50	1.17	2.18	0.17	0.00
Synoviocyte, donor3	11440-118H9	29.71	3.35	1.12	0.89	0.45	0.89	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	30.02	20.73	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	9.91	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	19.22	12.50	0.46	0.00	0.00	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	18.57	5.52	0.43	0.14	0.14	0.14	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	8.50	3.48	0.77	0.77	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	11.45	6.30	0.57	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	97.93	13.90	0.74	0.62	0.25	0.37	0.00
Urethra, donor2	10319-105A4	158.26	25.18	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	21.52	3.72	0.53	0.00	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	17.22	4.41	0.40	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	17.42	1.83	0.00	0.00	0.23	0.00	0.23
Urothelial cells, donor0	11216-116B1	50.82	4.46	0.45	0.00	0.45	1.11	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	153.04	14.24	4.45	0.00	1.78	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	165.83	11.44	4.29	4.29	2.86	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	69.14	11.64	4.79	4.11	1.37	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	81.61	12.74	2.75	0.34	1.03	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	84.25	13.36	3.49	1.74	2.32	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	111.41	11.45	3.12	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	131.24	22.94	2.75	0.92	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	68.47	12.78	2.74	2.74	2.74	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	40.71	25.17	2.34	1.11	0.99	0.12	0.12
Wilms' tumor cell line:HFWT	10597-108E3	33.44	3.52	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	58.94	17.88	0.56	0.28	0.56	0.00	0.28
achilles tendon, donor2	10292-104G4	82.66	2.07	0.00	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	38.24	45.13	1.27	1.27	1.53	2.55	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	92.17	57.81	1.86	0.23	1.16	0.93	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	151.59	111.59	4.87	1.31	2.61	1.66	1.19
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	58.23	83.27	1.90	3.54	3.27	3.54	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	32.32	37.95	3.09	0.84	1.12	0.56	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	69.58	35.95	3.38	0.63	0.85	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	37.84	42.47	2.45	0.54	0.00	0.82	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	44.06	27.76	3.08	0.44	0.88	0.44	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	42.06	33.89	3.68	1.23	0.82	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	78.05	46.21	5.82	1.16	1.94	1.16	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	12.88	23.55	1.29	0.37	0.18	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	109.21	27.30	15.60	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	62.05	39.97	2.32	0.93	1.16	0.70	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	51.78	37.28	4.66	2.07	1.04	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	46.76	30.39	1.46	0.58	1.75	0.88	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	41.83	26.49	0.00	0.00	0.00	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	48.53	32.08	0.41	1.23	0.41	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.33	34.69	3.38	0.00	0.92	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	37.98	47.79	5.55	0.85	0.43	0.43	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	58.84	50.65	4.25	1.52	0.00	0.91	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	44.05	49.10	5.05	0.96	0.72	0.24	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	21.83	30.74	0.67	0.45	1.56	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	67.04	21.68	1.67	1.00	0.67	1.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	107.78	44.60	1.86	0.00	0.00	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	55.37	44.07	0.38	2.64	0.00	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	111.65	28.78	6.11	1.31	0.00	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	149.96	48.74	1.87	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	45.69	24.73	0.47	0.24	0.24	0.24	0.47
adipose tissue, adult, pool1	10010-101C1	76.63	10.39	1.71	0.78	0.62	0.00	0.16
adipose, donor1	10184-103D4	111.42	38.70	4.10	6.45	1.76	2.35	0.00
adipose, donor2	10185-103D5	38.93	61.23	5.27	0.00	0.41	0.81	0.00
adipose, donor3	10186-103D6	49.28	52.82	5.17	0.00	0.00	0.00	0.00
adipose, donor4	10187-103D7	29.47	25.14	5.20	0.00	0.00	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	56.50	27.78	0.95	0.16	0.16	0.00	0.16
adrenal gland, adult, pool1	10081-102A9	29.10	14.55	0.00	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	80.98	52.96	0.93	0.93	1.07	0.93	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	31.44	19.65	1.43	0.71	0.00	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	62.14	8.81	0.93	0.46	1.16	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	73.03	14.20	1.01	0.34	0.34	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	69.53	4.71	0.00	0.88	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	79.45	17.79	3.56	1.19	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	151.47	22.30	5.88	1.82	0.61	1.22	0.61
amygdala, newborn, donor10223	10360-105E9	42.28	19.37	5.16	0.32	0.65	1.29	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	75.25	8.40	0.64	0.51	0.00	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	31.55	16.99	0.66	0.00	0.88	0.44	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	91.19	53.11	1.34	1.00	2.34	2.00	0.00
aorta, adult, pool1	10052-101G7	71.00	7.85	0.00	1.18	0.39	0.39	0.00
appendix, adult	10189-103D9	109.84	27.17	1.94	0.39	0.39	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	69.47	17.88	1.72	0.69	1.72	0.34	1.72
artery, adult	10190-103E1	57.06	9.51	0.00	1.36	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	66.49	20.14	2.61	0.43	0.72	0.29	0.14
b cell line:RPMI1788	10427-106D4	42.97	27.21	1.93	0.74	0.59	0.30	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	55.77	9.16	1.11	0.28	0.28	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	63.61	23.62	0.30	0.50	0.60	0.20	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	23.94	6.70	0.84	0.17	0.33	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	42.50	34.11	1.12	0.56	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	83.44	12.06	0.43	0.43	0.22	0.11	0.43
blood, adult, pool1	10053-101G8	39.86	6.64	0.00	4.43	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	93.34	11.13	0.00	1.71	0.00	0.00	0.86
bone marrow, adult	10192-103E3	53.31	10.12	1.35	1.35	0.00	0.00	0.67
brain, adult, donor1	10084-102B3	49.20	28.70	1.03	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	85.75	15.81	2.45	1.34	0.78	0.56	0.11
brain, fetal, pool1	10085-102B4	82.81	13.36	5.34	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	64.42	14.54	5.62	1.65	0.00	0.00	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	86.63	17.60	1.00	0.37	0.12	0.25	0.50
breast, adult, donor1	10080-102A8	61.87	13.89	0.63	0.00	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	21.22	20.83	0.51	0.38	0.00	0.25	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	51.33	14.84	0.00	1.55	0.62	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	43.97	28.78	0.23	4.14	3.68	0.69	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	45.75	25.42	0.48	0.48	0.97	0.48	0.24
carcinoid cell line:NCI-H1770	10703-109H1	67.23	60.65	1.41	0.47	2.35	2.82	0.47
carcinoid cell line:NCI-H727	10735-110B6	39.16	20.02	0.88	0.66	0.22	0.00	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	37.08	25.03	0.63	0.00	1.58	0.63	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	89.17	76.93	4.26	3.99	1.86	0.53	0.00
caudate nucleus - adult, donor10196	10177-103C6	90.95	40.30	3.45	1.15	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	153.10	20.25	4.85	2.84	0.50	0.33	1.00
caudate nucleus, adult, donor10258	10379-105H1	63.42	8.41	3.82	0.76	0.76	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	41.38	21.97	7.69	1.10	0.73	0.73	0.37
cerebellum - adult, donor10196	10173-103C2	163.14	14.57	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	219.92	18.79	6.41	2.14	0.64	0.21	0.85
cerebellum, adult, pool1	10083-102B2	48.64	5.52	3.45	2.41	2.76	0.69	0.69
cerebellum, newborn, donor10223	10357-105E6	185.15	29.89	9.96	1.66	1.66	0.00	0.00
cerebral meninges, adult	10188-103D8	107.92	13.36	5.04	0.25	0.00	0.76	0.25
cerebrospinal fluid, donor2	10294-104G6	57.01	10.23	1.46	0.73	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	74.62	34.65	2.16	0.14	0.72	0.58	0.14
cervical cancer cell line:ME-180	10553-107I4	35.63	19.72	2.15	0.17	0.33	0.17	0.00
cervix, adult, pool1	10013-101C4	132.71	13.54	1.15	1.26	0.42	0.42	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	57.41	9.75	1.39	0.70	0.98	0.28	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	40.49	3.92	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	38.65	28.21	1.37	0.50	0.25	0.62	0.25
choriocarcinoma cell line:SCH	10785-110H2	25.50	18.85	0.74	0.25	0.37	0.25	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	41.03	36.29	0.71	0.00	0.24	0.00	0.47
chorionic membrane cells, donor1	12238-129G6	46.44	11.11	0.28	1.14	0.57	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	55.38	11.04	0.89	0.60	0.30	0.10	0.10
chorionic membrane cells, donor3	12240-129G8	54.95	13.74	0.55	1.65	1.10	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	27.26	55.54	2.02	5.05	2.02	3.03	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	41.69	27.09	1.92	0.96	1.15	0.58	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	91.23	52.16	2.32	1.69	1.27	0.42	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	48.28	43.40	1.03	0.26	0.26	1.03	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	49.83	41.36	1.45	0.73	1.45	0.48	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	54.77	42.55	2.44	0.00	0.61	0.00	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	77.74	60.95	3.24	0.88	1.77	0.59	1.77
chronic myelogenous leukemia cell line:KU812	10409-106B4	98.00	49.26	5.21	0.78	0.00	0.26	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	69.72	16.46	1.60	3.66	3.43	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	58.65	17.18	0.17	0.69	0.35	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	42.47	27.46	0.92	0.37	0.37	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	57.39	42.19	1.52	0.38	0.00	0.00	0.76
colon, adult, donor1	10082-102B1	64.26	34.51	1.19	3.57	1.19	2.38	0.00
colon, adult, pool1	10014-101C5	89.77	13.40	0.71	0.35	0.00	0.24	0.12
colon, fetal, donor1	10070-101I7	79.72	14.83	0.62	0.62	0.62	2.47	0.00
common myeloid progenitor CMP, donor1	12130-128D6	293.35	87.09	4.58	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	125.18	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	67.14	45.47	2.55	0.00	0.85	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	32.75	26.26	1.81	0.15	0.91	0.75	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	36.80	27.22	1.97	0.28	0.42	0.42	0.00
corpus callosum, adult, pool1	10042-101F6	128.03	34.83	3.43	1.55	0.66	0.33	0.22
cruciate ligament, donor2	10295-104G7	132.11	16.21	0.81	0.81	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	72.23	20.87	1.61	0.80	0.80	0.00	0.00
diencephalon, adult	10193-103E4	58.32	15.60	2.64	0.72	0.00	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	30.54	49.60	2.07	3.21	1.61	1.84	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	85.91	26.16	0.26	0.51	0.00	0.26	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	53.44	22.39	1.44	1.20	1.69	0.24	0.00
ductus deferens, adult	10196-103E7	95.68	17.44	1.00	1.50	0.00	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	79.21	24.48	0.00	2.88	0.00	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	97.84	15.45	2.21	6.62	0.74	0.00	0.74
dura mater, adult, donor1	10041-101F5	78.79	15.28	4.46	0.50	0.50	0.17	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	8.88	39.53	2.44	0.00	0.00	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	27.66	29.95	2.87	0.14	0.43	0.43	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	54.26	6.17	1.23	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	47.53	5.15	0.00	0.61	0.61	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	65.76	8.34	0.93	0.62	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	80.12	5.25	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	49.94	11.40	1.34	0.00	0.67	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	77.03	19.03	0.72	2.72	3.26	0.54	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	23.96	8.36	0.80	1.45	0.96	0.32	0.16
epidermoid carcinoma cell line:A431	10426-106D3	65.81	33.35	0.56	0.11	0.33	0.11	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	60.38	29.70	0.77	0.33	0.44	0.22	0.22
epididymis, adult	10197-103E8	73.68	14.02	0.84	0.42	0.21	0.21	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	70.61	18.81	4.08	1.42	1.77	0.71	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	30.28	19.66	2.75	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	47.05	33.29	1.97	2.36	0.39	0.26	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	46.95	30.31	0.79	1.77	0.79	0.39	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	44.81	31.93	1.23	2.13	1.34	0.34	0.45
esophagus, adult, pool1	10015-101C6	66.68	12.10	0.74	0.53	0.85	0.21	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	108.96	16.41	8.39	1.00	0.38	0.25	0.13
eye - muscle inferior rectus, donor1	10272-104E2	86.92	26.56	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	86.27	8.42	0.00	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	93.76	16.37	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	89.43	14.90	1.15	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	67.04	11.66	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	56.44	7.37	2.03	1.02	0.51	0.25	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	29.36	14.10	0.51	0.13	0.13	0.13	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	35.38	30.15	1.66	0.47	0.71	0.24	0.71
frontal lobe, adult, pool1	10040-101F4	110.06	20.92	3.85	0.84	0.38	0.28	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	81.67	23.12	5.70	1.80	0.60	1.20	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	57.33	9.05	0.82	0.27	0.27	0.18	0.46
gall bladder, adult	10198-103E9	76.29	15.69	0.72	1.21	0.24	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	91.27	26.84	8.59	1.61	1.61	1.07	0.54
gamma delta positive T cells, donor2	11938-126A3	83.66	16.81	6.72	1.87	1.49	0.75	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	80.05	20.07	0.63	2.75	2.53	0.63	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	52.42	24.37	0.58	0.58	0.58	0.39	0.77
gastric cancer cell line:AZ521	10549-107H9	88.04	38.20	2.46	0.66	0.66	0.33	0.00
gastric cancer cell line:GSS	10560-108A2	41.19	10.07	0.00	0.00	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	62.14	49.80	5.48	3.43	1.37	0.69	0.69
giant cell carcinoma cell line:LU65	10487-107B1	17.56	6.88	1.38	0.34	1.03	0.00	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	66.20	8.40	0.56	0.14	0.00	0.28	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	60.36	15.46	0.25	0.75	0.25	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	36.42	11.51	0.84	0.53	0.00	0.11	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	49.43	10.39	0.70	0.42	0.42	0.14	0.56
glioblastoma cell line:T98G	10485-107A8	65.34	31.35	0.99	0.99	0.33	0.44	0.00
glioma cell line:GI-1	10413-106B8	52.43	14.35	0.88	0.29	0.59	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	94.76	27.70	1.46	0.00	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	199.67	51.02	4.88	2.44	0.49	0.73	0.49
globus pallidus, adult, donor10258	10367-105F7	128.71	27.38	1.37	4.11	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	36.24	18.12	5.33	0.53	1.07	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	232.48	53.84	12.24	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	21.86	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	20.91	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	41.60	14.40	0.00	1.92	0.64	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	15.15	16.07	0.46	0.46	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	16.00	16.00	0.46	0.91	0.46	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	3.22	17.39	1.93	0.00	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	11.50	31.62	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	4.80	11.66	1.37	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	48.55	16.55	2.21	0.00	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	31.90	17.82	2.30	1.15	0.86	0.57	0.57
heart - mitral valve, adult	10205-103F7	76.83	12.86	2.39	1.20	0.00	0.30	0.60
heart - pulmonic valve, adult	10206-103F8	89.95	12.29	0.00	1.83	0.00	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	87.43	63.28	4.16	1.67	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	48.97	13.67	0.61	2.65	1.43	1.02	0.20
heart, adult, diseased, donor1	10051-101G6	51.53	6.39	0.00	0.00	0.00	0.00	0.43
heart, adult, pool1	10016-101C7	57.95	6.44	0.46	0.00	0.00	0.92	0.00
heart, fetal, pool1	10046-101G1	104.01	23.31	1.95	0.62	0.51	0.00	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	51.83	7.71	1.23	0.31	0.62	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	109.40	74.92	1.19	1.19	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	31.49	25.64	1.44	0.99	0.66	0.33	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	36.90	29.86	1.34	2.79	0.24	0.12	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	39.61	30.52	0.61	0.51	0.40	0.30	0.40
hepatoma cell line:Li-7	10484-107A7	34.14	6.90	0.78	0.22	0.44	0.11	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	25.83	37.69	1.21	0.90	0.50	0.40	0.70
hippocampus - adult, donor10196	10169-103B7	72.87	15.14	0.95	0.95	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	160.83	24.90	4.49	2.25	1.02	0.41	0.20
hippocampus, adult, donor10258	10374-105G5	52.28	12.45	1.49	0.50	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	34.54	15.86	11.28	0.00	1.06	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	20.14	29.30	1.83	0.61	0.61	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	11.78	24.15	1.37	0.20	0.59	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	10.41	21.07	2.79	0.25	0.51	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	30.45	47.93	1.13	0.56	1.13	0.00	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	32.79	62.75	1.81	6.20	4.39	1.03	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	35.68	40.62	2.66	0.76	1.14	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	62.77	57.22	9.05	1.17	0.29	0.88	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	52.35	84.88	6.25	1.29	1.29	0.65	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	50.05	71.74	9.59	0.42	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	67.49	38.60	8.52	0.95	0.71	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	56.09	50.47	7.07	1.93	1.29	1.45	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	71.37	49.15	10.77	0.67	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	8.14	23.16	1.41	1.10	0.47	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	7.37	28.50	1.47	1.47	0.98	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	8.73	16.58	2.62	1.75	2.62	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	50.97	70.83	0.95	1.34	0.19	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	45.79	71.52	2.18	0.87	0.44	0.44	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	61.47	35.48	0.50	1.00	1.00	2.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	35.23	51.05	5.09	1.32	0.57	0.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	29.56	50.93	4.55	0.45	1.36	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	36.34	37.59	3.76	0.94	0.94	2.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	48.34	37.07	4.57	1.31	0.98	0.49	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	45.87	33.97	4.06	0.87	0.58	1.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	43.64	29.89	5.98	0.60	1.20	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	11.08	31.22	1.29	0.55	0.00	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	13.41	31.95	0.57	0.57	0.00	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	17.15	28.99	2.45	1.22	0.82	1.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	49.64	44.71	2.46	2.11	1.06	1.41	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	38.01	52.26	1.58	0.63	0.32	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	38.74	29.35	3.63	0.30	1.21	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	49.13	53.78	5.17	0.52	0.00	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	39.85	63.76	3.32	0.66	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	52.85	29.24	3.33	1.28	0.51	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	44.74	29.66	4.35	2.56	0.77	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	60.58	46.95	4.54	1.51	2.27	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	33.94	25.20	5.38	0.34	1.01	0.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	9.18	34.54	2.17	0.48	0.00	0.48	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	10.70	25.85	2.67	2.23	1.34	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	10.73	27.32	1.95	0.00	0.00	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	40.95	47.37	1.22	1.53	0.00	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	253.75	126.88	3.25	29.28	9.76	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	50.30	33.43	2.65	1.99	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	45.43	65.68	7.11	2.19	1.64	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	49.22	43.79	5.79	1.45	0.36	1.09	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	34.52	44.48	4.63	1.07	1.07	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	42.96	38.19	2.39	1.19	1.19	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	66.90	35.75	7.99	0.54	1.63	0.95	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	36.91	32.60	5.12	0.81	1.35	0.27	0.54
immature langerhans cells, donor1	11904-125F5	51.82	4.36	0.97	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	34.06	12.67	2.38	0.00	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	109.21	19.68	4.35	0.57	0.76	0.19	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	31.21	29.91	0.65	1.30	0.33	0.33	0.98
kidney, adult, pool1	10017-101C8	65.28	10.01	2.20	0.90	0.30	0.20	0.00
kidney, fetal, pool1	10045-101F9	103.84	18.18	2.62	0.71	0.42	0.14	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	80.81	15.48	1.14	0.28	0.14	0.28	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	16.87	4.84	0.00	0.28	0.41	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	51.93	17.62	0.73	0.00	0.18	0.00	0.18
left atrium, adult, donor1	10079-102A7	41.41	2.72	0.00	1.09	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	28.32	6.07	0.51	0.51	0.51	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	43.50	26.54	1.64	0.55	0.55	0.27	0.55
leiomyoma cell line:10964C	10569-108B2	20.12	4.67	0.00	1.44	0.36	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	19.57	6.52	0.00	1.09	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	25.74	6.56	0.49	1.70	0.73	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	88.89	12.70	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	127.56	15.68	1.05	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	54.19	33.17	2.36	1.53	0.35	0.24	0.47
liposarcoma cell line:KMLS-1	10782-110G8	32.02	13.12	0.16	0.62	0.31	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	54.71	20.35	0.37	0.73	0.37	0.85	0.37
liver, adult, pool1	10018-101C9	41.33	9.56	0.81	0.32	0.00	0.16	0.32
liver, fetal, pool1	10086-102B5	13.17	20.70	0.94	0.00	1.88	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	81.08	20.56	3.65	0.15	0.15	0.29	0.15
locus coeruleus, adult, donor10252	10165-103B3	126.60	25.10	4.61	1.66	0.55	0.92	0.00
locus coeruleus, adult, donor10258	10375-105G6	31.32	18.34	0.85	0.56	1.41	0.56	0.00
locus coeruleus, newborn, donor10223	10362-105F2	51.32	19.77	7.57	0.84	0.42	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	36.12	11.35	0.69	0.00	0.14	0.14	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	68.25	11.72	1.38	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	69.60	22.67	0.66	0.40	0.13	0.13	0.66
lung, adult, pool1	10019-101D1	65.56	9.57	1.42	0.59	0.24	0.00	0.47
lung, fetal, donor1	10068-101I5	295.11	25.69	5.14	0.29	0.00	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	44.91	16.50	2.29	0.92	2.29	0.92	0.46
lymph node, adult, donor1	10077-102A5	28.88	7.57	1.89	1.42	0.47	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	40.99	21.26	0.22	1.10	1.32	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	26.11	38.79	4.53	0.75	0.60	0.15	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	93.44	27.18	1.70	0.85	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	108.78	10.21	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	96.50	8.92	0.42	0.42	0.42	0.00	0.00
mature adipocyte, donor3	12233-129G1	95.30	7.82	1.19	0.47	0.24	0.24	0.00
mature adipocyte, donor4	12234-129G2	131.35	13.69	0.79	0.26	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	132.00	33.36	4.53	0.24	0.48	0.00	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	91.37	18.05	2.26	1.13	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	139.77	24.28	6.07	1.84	1.10	0.18	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	62.58	10.17	3.18	1.27	0.00	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	75.49	22.18	8.96	0.85	0.00	0.43	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	87.92	20.08	3.04	8.44	4.56	1.18	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	167.45	27.16	6.79	2.33	1.49	0.21	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	94.39	17.34	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	200.95	71.77	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	36.25	19.02	6.10	0.36	0.72	0.72	0.00
medulla oblongata - adult, donor10196	10174-103C3	85.02	9.73	1.30	0.00	0.65	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	131.12	22.45	3.25	1.86	0.62	0.46	0.00
medulla oblongata, adult, pool1	10038-101F2	99.91	21.47	4.16	0.49	0.24	0.00	0.16
medulla oblongata, newborn, donor10223	10361-105F1	50.69	28.12	8.33	1.74	1.74	1.39	0.35
medulloblastoma cell line:D283 Med	10838-111E1	56.24	44.50	1.77	2.88	0.89	0.89	0.44
medulloblastoma cell line:ONS-76	10759-110E3	52.21	26.90	0.98	0.24	0.37	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	35.07	20.12	3.45	0.29	0.14	0.00	0.14
melanoma cell line:G-361	10465-106H6	36.38	13.57	1.90	0.81	1.63	0.54	0.00
meningioma cell line:HKBMM	10691-109F7	30.57	6.51	0.00	1.99	1.09	0.36	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	144.51	80.19	6.17	8.81	4.41	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	167.20	109.91	12.18	3.63	1.81	1.56	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	42.19	10.89	0.46	1.38	0.77	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	38.36	6.54	0.55	0.73	0.55	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	23.60	4.14	0.83	0.83	0.41	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	37.37	5.34	0.28	0.84	0.28	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	35.82	6.16	0.58	0.58	0.58	0.39	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	23.60	5.55	0.00	0.69	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	30.89	5.15	0.00	0.51	0.17	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	37.15	6.10	0.58	1.04	0.92	0.46	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	33.56	9.68	0.66	0.66	0.93	0.13	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	36.60	10.94	0.81	0.81	0.41	0.00	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	43.67	11.95	1.00	0.57	0.57	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	44.13	3.29	0.33	1.65	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	37.78	8.30	0.69	1.25	0.00	0.42	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	26.53	9.43	0.35	0.00	0.35	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	45.32	4.70	1.02	0.82	0.20	0.61	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	23.72	3.59	0.72	0.36	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	35.17	4.24	0.21	0.83	0.31	0.31	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	14.36	2.74	0.23	0.23	0.23	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	47.83	13.85	0.84	1.26	0.84	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	41.39	7.17	1.20	0.30	0.30	0.15	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	30.46	5.51	0.61	1.14	1.31	0.09	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	52.65	4.42	1.10	0.74	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	27.18	7.73	2.00	0.29	0.00	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	53.05	22.73	1.26	7.16	1.68	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	29.23	4.57	0.46	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	24.56	5.63	0.77	0.26	0.00	0.00	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	28.27	7.85	0.52	0.00	1.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	26.50	5.24	1.23	0.31	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	23.30	7.06	0.94	0.47	0.94	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	32.15	6.43	0.68	0.68	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	25.54	5.50	0.79	0.39	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	23.17	4.17	0.93	0.93	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	31.44	5.19	0.87	0.29	0.29	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	29.23	6.02	0.22	0.00	0.22	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	28.60	7.69	0.72	0.96	0.24	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	34.47	9.53	0.73	1.47	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	19.13	5.03	0.34	0.34	1.01	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	24.97	4.91	0.00	0.82	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	25.77	6.01	1.29	0.00	0.43	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	30.08	2.73	0.00	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	51.65	5.16	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	28.58	4.87	0.65	0.00	0.00	0.65	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	24.73	8.73	0.00	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	36.78	5.33	0.00	1.07	0.53	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	30.26	9.81	0.00	0.00	1.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	29.54	7.77	1.17	0.39	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	33.58	4.20	0.00	0.00	2.10	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	30.80	2.98	0.00	1.99	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	4.77	0.00	0.00	4.77	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	29.65	5.34	1.19	0.00	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	23.15	2.44	0.00	2.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	38.64	5.07	0.00	0.63	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	24.14	5.86	0.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	32.24	8.60	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	0.00	3.99	3.99	0.00	7.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	41.33	13.78	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	22.82	11.41	0.00	1.22	0.41	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	15.89	11.12	0.79	0.00	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	15.92	7.66	0.59	0.59	1.77	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	23.69	12.16	0.62	0.00	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	21.39	8.02	0.00	2.67	1.34	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	10.64	10.64	0.00	2.37	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	15.41	0.00	0.00	7.70	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	31.67	8.95	0.69	2.07	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	19.79	13.85	0.49	1.48	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	19.07	12.34	1.12	1.12	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	21.63	20.99	1.91	0.64	1.27	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	29.42	14.10	0.81	0.40	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	21.81	13.08	0.00	4.36	4.36	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	30.41	12.67	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	24.88	3.03	0.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	4.52	0.00	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	23.89	15.65	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	29.76	9.33	0.79	0.40	0.79	0.40	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	24.66	13.30	0.32	0.32	0.32	1.62	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	22.41	9.17	0.00	0.00	3.06	2.04	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	100.58	13.93	4.64	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	86.23	17.25	3.07	0.71	0.47	0.24	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	74.60	26.18	4.17	0.70	1.85	0.70	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	12.82	0.00	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	30.52	9.25	0.82	1.64	2.26	0.51	0.10
mesothelioma cell line:Mero-25	10850-111F4	15.66	10.89	0.23	0.45	0.23	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	54.27	29.09	1.22	0.98	0.98	0.98	0.49
mesothelioma cell line:Mero-48a	10852-111F6	20.59	11.51	0.44	0.22	0.00	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	39.68	26.54	0.53	2.10	1.31	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	24.17	12.77	0.68	0.85	0.51	0.17	0.17
mesothelioma cell line:Mero-84	10855-111F9	9.61	20.47	0.00	0.76	0.25	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	32.51	15.53	0.62	0.62	0.21	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	29.82	16.90	1.66	0.83	0.17	0.17	0.33
mesothelioma cell line:NCI-H226	10846-111E9	27.51	18.82	1.63	0.72	0.18	0.54	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	55.86	29.72	1.20	0.85	1.54	0.51	0.00
mesothelioma cell line:NCI-H28	10845-111E8	22.65	8.14	0.76	0.76	0.51	0.25	0.00
mesothelioma cell line:No36	10857-111G2	31.64	9.13	1.30	2.28	0.65	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	32.79	20.32	0.81	0.81	0.54	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	61.99	9.40	0.58	0.58	0.19	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	53.85	4.76	0.85	0.24	0.24	0.12	0.24
migratory langerhans cells, donor3	11903-125F4	45.95	5.38	0.90	0.00	0.18	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	41.14	9.79	1.31	2.94	2.29	0.98	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	29.25	16.95	0.00	1.06	0.85	0.21	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	48.61	13.36	0.23	0.23	0.46	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	25.88	20.55	0.95	0.57	0.57	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	59.32	51.19	4.44	0.92	1.48	0.37	0.74
myeloma cell line:PCM6	10474-106I6	50.21	15.42	0.00	0.99	0.99	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	88.27	9.13	0.51	0.00	0.00	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	49.43	23.34	0.78	0.20	1.37	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	24.29	4.35	0.22	0.11	0.11	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	23.68	3.09	0.07	0.22	0.00	0.15	0.22
nasal epithelial cells, donor2	12227-129F4	30.36	6.07	1.10	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	55.67	26.69	2.07	0.23	0.00	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	46.02	25.63	1.31	0.19	0.19	0.19	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	41.76	24.88	1.69	1.05	0.42	0.63	0.00
neuroblastoma cell line:NH-12	10555-107I6	40.25	19.75	1.68	0.75	0.56	0.37	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	88.96	10.91	1.19	2.85	1.42	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	70.48	27.40	2.53	1.90	1.11	2.22	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	55.75	25.36	1.61	0.60	1.21	1.81	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	142.41	26.70	1.27	0.64	1.27	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	40.99	14.11	0.27	0.27	0.27	0.00	0.00
neutrophil PMN, donor1	12133-128D9	505.74	44.62	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	132.81	26.56	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	28.41	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	191.61	174.70	3.21	2.20	2.54	1.01	3.04
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	33.62	8.81	1.60	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	36.87	11.22	0.64	0.96	1.92	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	40.73	8.93	1.05	3.15	0.79	0.53	0.26
nucleus accumbens, adult, pool1	10037-101F1	116.05	22.12	4.03	0.66	0.28	0.37	0.19
occipital cortex - adult, donor10196	10172-103C1	82.42	18.54	12.36	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	201.81	33.01	6.44	3.22	0.81	0.81	0.00
occipital cortex, newborn, donor10223	10355-105E4	53.14	20.74	4.73	0.36	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	61.66	12.86	5.51	0.79	0.52	2.36	0.00
occipital lobe, fetal, donor1	10073-102A1	201.25	40.76	6.01	2.57	2.57	0.43	0.43
occipital pole, adult, pool1	10036-101E9	81.13	14.51	3.00	0.39	0.16	0.24	0.00
olfactory region, adult	10195-103E6	89.03	17.96	3.25	1.91	0.38	0.19	0.19
optic nerve, donor1	10277-104E7	172.09	46.02	10.01	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	15.72	14.92	0.57	0.34	0.23	0.34	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	30.23	24.87	0.14	0.14	0.41	0.27	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	44.02	12.70	1.35	2.03	0.85	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	27.72	12.59	0.23	0.35	0.58	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	66.44	15.87	1.47	0.59	0.59	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	134.54	27.10	4.67	0.00	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	53.01	29.90	1.91	0.21	1.06	0.21	0.42
ovary, adult, pool1	10020-101D2	89.88	11.01	0.70	0.26	0.61	0.17	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	39.60	13.38	0.18	0.37	0.37	0.18	0.00
pancreas, adult, donor1	10049-101G4	37.63	14.11	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	29.91	27.95	2.80	0.56	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	48.21	12.10	0.51	2.38	1.19	0.51	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	60.60	11.09	0.00	0.17	0.50	0.00	0.17
paracentral gyrus, adult, pool1	10035-101E8	94.82	17.48	5.13	0.82	0.73	0.00	0.18
parietal cortex, adult, donor10258	10373-105G4	66.79	9.54	4.40	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	87.46	17.87	2.82	0.00	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	143.94	23.66	3.14	3.71	0.29	0.57	0.57
parietal lobe, adult, pool1	10034-101E7	98.52	24.32	4.67	0.88	0.35	0.09	0.35
parietal lobe, fetal, donor1	10072-101I9	241.49	28.13	6.79	2.91	6.79	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	47.85	22.81	5.23	0.00	0.37	0.00	0.00
parotid gland, adult	10199-103F1	65.98	11.10	0.62	1.23	0.00	0.00	0.00
penis, adult	10200-103F2	69.29	7.52	0.54	1.61	2.15	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	67.49	21.75	2.42	2.05	0.37	0.19	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	28.12	10.78	1.17	0.15	0.44	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	83.21	13.55	0.65	0.00	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	162.27	25.47	2.96	0.59	0.59	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	62.08	10.03	1.25	0.00	0.00	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	75.89	24.28	4.05	0.00	0.00	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	193.36	44.82	5.21	0.52	1.04	0.00	1.56
pituitary gland, adult, donor10258	10378-105G9	38.31	5.96	4.26	0.00	0.85	0.00	0.85
placenta, adult, pool1	10021-101D3	120.30	9.78	1.94	0.11	0.11	0.65	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	27.15	31.25	1.72	0.40	1.06	0.26	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	102.88	24.28	0.93	1.09	0.93	0.93	0.31
pons, adult, pool1	10033-101E6	82.71	17.30	5.94	0.69	0.69	0.00	0.34
postcentral gyrus, adult, pool1	10032-101E5	87.44	15.08	4.36	0.96	0.61	0.09	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	184.04	27.19	4.18	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	41.37	28.84	0.29	0.58	1.17	0.29	0.73
prostate cancer cell line:PC-3	10439-106E7	83.49	29.58	0.73	0.73	1.45	0.54	0.18
prostate, adult, pool1	10022-101D4	97.67	12.33	0.63	0.54	0.18	0.45	0.09
putamen, adult, donor10196	10176-103C5	131.72	21.95	2.60	2.60	0.00	0.00	0.00
putamen, adult, donor10252	10152-102I8	180.39	29.41	7.84	1.96	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	32.78	19.67	1.09	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	61.85	15.70	3.87	0.48	0.48	0.48	0.97
putamen, newborn, donor10223	10365-105F5	29.24	29.24	7.50	0.00	0.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	59.93	28.51	1.75	0.58	0.00	0.29	0.29
rectum, fetal, donor1	10067-101I4	109.89	45.90	4.17	1.39	5.56	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	57.66	12.30	0.42	0.42	1.06	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	74.14	13.67	0.41	2.49	1.24	1.24	1.24
retina, adult, pool1	10030-101E3	88.27	16.00	3.48	0.89	0.50	0.60	0.10
retinoblastoma cell line:Y79	10475-106I7	101.32	45.98	4.68	1.04	1.04	1.82	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	50.41	26.19	1.23	0.37	0.49	0.86	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	140.88	65.80	2.81	1.12	0.56	1.41	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	115.95	8.34	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	27.19	14.08	0.32	0.65	0.32	0.16	0.00
salivary acinar cells, donor2	11772-123I8	36.07	15.97	1.24	0.69	0.69	0.69	0.14
salivary acinar cells, donor3	11773-123I9	81.43	26.48	1.32	0.00	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	102.38	13.15	0.57	0.57	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	44.35	12.06	0.93	0.59	0.34	0.25	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	40.44	12.23	0.59	0.24	0.82	0.47	0.12
seminal vesicle, adult	10201-103F3	104.76	17.99	0.00	0.53	0.53	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	42.51	20.89	1.46	2.43	0.97	0.49	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	51.08	4.28	0.75	1.01	0.25	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	44.16	8.03	3.01	0.00	2.01	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	66.49	16.12	1.61	1.48	1.21	0.81	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	71.18	41.01	1.22	0.77	0.33	0.77	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	47.61	23.35	0.52	0.52	0.13	0.26	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	78.74	12.77	2.13	2.84	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	48.21	10.67	0.48	0.12	0.24	0.12	0.24
skeletal muscle, fetal, donor1	10066-101I3	32.16	6.03	1.01	1.01	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	54.28	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	106.68	18.31	1.89	1.89	0.00	1.89	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	54.03	57.03	3.00	1.00	2.33	1.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	120.09	38.77	3.15	3.15	0.95	1.89	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	99.27	37.01	8.10	2.12	2.51	0.19	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	66.26	31.32	1.32	0.33	0.33	0.33	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	79.30	55.98	0.64	0.97	1.29	1.13	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	88.47	32.69	0.87	0.87	0.44	0.87	0.22
small intestine, adult, pool1	10024-101D6	90.54	20.31	1.19	0.72	0.24	0.48	0.24
small intestine, fetal, donor1	10064-101I1	57.00	14.25	1.47	2.46	2.21	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	35.90	29.75	3.59	4.10	1.03	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	88.65	14.73	0.00	0.78	0.78	0.26	0.78
somatostatinoma cell line:QGP-1	10781-110G7	44.22	6.43	0.00	0.27	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	79.83	22.48	1.61	1.15	0.46	1.38	0.69
spinal cord, adult, donor10252	10159-103A6	149.03	31.54	3.15	0.79	0.39	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	53.96	15.91	2.08	0.00	0.69	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	96.35	26.83	3.66	1.83	0.00	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	94.60	32.14	9.18	0.92	0.46	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	54.66	7.77	0.15	0.30	0.75	0.00	0.00
spleen, adult, pool1	10025-101D7	60.68	10.13	2.86	0.11	0.33	0.11	0.11
spleen, fetal, pool1	10044-101F8	102.34	20.26	4.61	0.32	0.16	0.24	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	31.16	22.26	0.31	0.41	0.21	0.21	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	38.92	6.46	0.38	0.19	0.57	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	75.48	12.23	0.35	3.49	1.05	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	24.63	15.64	0.78	0.78	0.00	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	58.42	15.08	3.60	0.45	0.45	0.56	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	16.94	11.44	0.00	0.85	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	53.31	31.73	1.27	0.85	0.42	0.42	0.42
stomach, fetal, donor1	10062-101H8	91.85	21.36	1.07	0.00	2.14	0.00	1.07
submaxillary gland, adult	10202-103F4	70.07	14.81	0.57	0.00	0.00	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	108.55	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	117.77	33.65	2.91	2.08	1.45	0.83	0.62
substantia nigra, adult, donor10258	10371-105G2	45.00	9.31	4.14	0.52	0.52	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	62.89	33.92	5.65	1.41	1.41	1.41	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	69.70	42.18	3.21	1.38	0.23	0.92	0.00
temporal lobe, adult, pool1	10031-101E4	74.77	15.77	4.15	0.93	0.34	0.00	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	242.88	39.17	6.41	4.27	0.00	1.42	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	182.85	25.93	5.27	1.32	0.88	0.88	0.00
tenocyte, donor1	11763-123H8	52.02	11.52	0.35	2.44	2.44	0.35	0.35
tenocyte, donor2	11765-123I1	46.54	5.34	0.38	1.53	0.38	1.14	0.38
tenocyte, donor3	11768-123I4	42.26	7.04	0.37	1.11	0.74	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	26.68	66.79	7.48	1.36	0.68	0.17	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	35.92	32.22	0.92	0.77	0.62	0.46	0.00
teratocarcinoma cell line:PA-1	10807-111A6	17.51	34.87	2.01	0.46	0.46	0.77	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	18.28	28.56	4.06	0.13	0.13	0.13	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	19.66	17.40	6.05	0.38	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	23.23	20.07	5.67	0.44	0.22	0.22	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	15.31	19.54	10.10	1.30	1.63	0.00	0.00
testis, adult, pool1	10026-101D8	60.02	11.92	6.01	0.54	0.32	0.11	0.00
testis, adult, pool2	10096-102C6	78.94	18.95	21.20	0.90	0.45	0.00	0.00
thalamus - adult, donor10196	10168-103B6	113.71	28.70	4.42	0.00	1.10	1.10	0.00
thalamus, adult, donor10252	10154-103A1	158.94	39.70	3.13	1.88	0.94	0.78	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	103.15	18.48	1.54	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	31.95	15.65	1.48	1.15	0.99	0.66	0.16
thalamus, newborn, donor10223	10366-105F6	27.62	6.90	6.90	0.00	0.58	0.58	0.00
throat, adult	10209-103G2	70.91	17.98	1.00	1.25	0.00	0.25	0.50
throat, fetal, donor1	10061-101H7	102.08	24.68	3.05	1.83	0.91	1.52	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	62.60	32.59	0.79	0.99	0.99	1.19	0.79
thymus, adult, pool1	10027-101D9	113.93	43.84	3.58	0.40	0.20	0.00	0.89
thymus, fetal, pool1	10043-101F7	159.18	66.19	5.82	0.83	1.25	0.31	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	44.28	15.29	0.66	0.53	0.66	0.40	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	71.66	23.47	1.12	1.12	0.28	1.26	0.28
thyroid, adult, pool1	10028-101E1	91.07	12.50	1.96	0.56	0.37	0.09	0.19
thyroid, fetal, donor1	10060-101H6	107.05	22.15	2.64	0.26	0.26	1.05	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	141.66	15.40	6.16	3.08	3.08	0.00	0.00
tongue, adult	10203-103F5	54.42	15.35	0.70	1.40	0.47	0.00	1.16
tongue, fetal, donor1	10059-101H5	58.33	15.76	1.18	1.18	0.00	0.79	0.79
tonsil, adult, pool1	10047-101G2	87.75	21.14	1.80	0.30	0.40	0.10	0.20
trachea, adult, pool1	10029-101E2	53.01	10.14	0.90	0.25	0.08	0.16	0.16
trachea, fetal, donor1	10058-101H4	70.78	17.70	1.92	1.54	0.77	1.15	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	36.49	13.11	1.42	0.71	0.71	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	88.65	29.48	3.04	0.51	0.71	0.10	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	127.07	40.11	2.04	3.45	1.88	2.04	0.47
tridermal teratoma cell line:HGRT	10694-109G1	159.81	11.42	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	22.43	7.11	0.59	0.25	0.34	0.00	0.00
umbilical cord, fetal, donor1	10057-101H3	62.60	8.35	0.00	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	201.85	13.48	2.39	1.02	0.34	0.68	0.00
uterus, fetal, donor1	10055-101H1	102.90	31.23	2.05	1.54	2.56	0.00	0.00
vagina, adult	10204-103F6	102.10	37.48	3.23	0.65	0.00	0.00	1.29
vein, adult	10191-103E2	67.07	11.40	1.53	1.10	0.22	0.44	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	23.50	11.22	0.27	0.27	0.27	0.27	0.27